Go to the Table of Contents


Please note: A selected table may take a few minutes to load.

240520
Table 5.1A – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2022 and 2023
Substance Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE DISORDER 48,722 48,464 2,228 2,192 46,494 46,272 9,669 9,228 36,825 37,044
DRUGS 27,230 27,153 1,813 1,780 25,417 25,373 6,482 6,113 18,935 19,260
Marijuana 18,976 19,164 1,308 1,223 17,669 17,941 5,740 5,634 11,928 12,308
Cocaine 1,435 1,256 6a 45 1,429 1,212 268 189 1,161 1,023
Heroin 900a 587 2 * 898a 587 35 17 864a 570
Hallucinogens 592 428 78 59 514 369 228a 132 286 237
Inhalants 332 304 70 78 262 226 91 39 171 187
Methamphetamine 1,826 1,784 8 23 1,818 1,761 84 71 1,734 1,690
Prescription Psychotherapeutics 8,227 7,889 541 598 7,687 7,292 945 769 6,742 6,523
Pain Relievers 5,577 5,344 265 316 5,312 5,027 410 392 4,902 4,636
Stimulants 1,828 1,718 259 244 1,569 1,474 476a 315 1,093 1,158
Tranquilizers or Sedatives 2,355 2,256 135 140 2,221 2,116 290 222 1,931 1,894
Tranquilizers 1,807 1,747 77 89 1,730 1,659 236 162 1,495 1,497
Sedatives 833 869 64 72 769 797 81 77 688 720
Opioids 6,117 5,679 265 316 5,852 5,363 424 396 5,427 4,967
Central Nervous System Stimulants 4,515 4,322 267 268 4,247 4,053 755b 525 3,492 3,529
ALCOHOL 29,542 28,859 753 757 28,788 28,103 5,689a 5,123 23,099 22,980
BOTH DRUGS AND ALCOHOL 8,049 7,549 338 345 7,712 7,204 2,502b 2,008 5,209 5,197
DRUGS ONLY (NO ALCOHOL USE DISORDER) 19,180 19,604 1,475 1,435 17,706 18,169 3,980 4,105 13,726 14,064
ALCOHOL ONLY (NO DRUG USE DISORDER) 21,492 21,311 415 412 21,077 20,899 3,186 3,115 17,890 17,784
NO SUBSTANCE USE DISORDER 233,285 234,994 23,498 23,723 209,788 211,270 25,118 24,805 184,670 186,465
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.1B – Substance Use Disorder for Specific Substances in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2022 and 2023
Substance Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE DISORDER 17.3 17.1 8.7 8.5 18.1 18.0 27.8 27.1 16.6 16.6
DRUGS 9.7 9.6 7.0 6.9 9.9 9.9 18.6 18.0 8.5 8.6
Marijuana 6.7 6.8 5.1 4.7 6.9 7.0 16.5 16.6 5.4 5.5
Cocaine 0.5 0.4 <0.1a 0.2 0.6 0.5 0.8 0.6 0.5 0.5
Heroin 0.3a 0.2 <0.1 * 0.4a 0.2 0.1 <0.1 0.4a 0.3
Hallucinogens 0.2 0.2 0.3 0.2 0.2 0.1 0.7a 0.4 0.1 0.1
Inhalants 0.1 0.1 0.3 0.3 0.1 0.1 0.3 0.1 0.1 0.1
Methamphetamine 0.6 0.6 <0.1 0.1 0.7 0.7 0.2 0.2 0.8 0.8
Prescription Psychotherapeutics 2.9 2.8 2.1 2.3 3.0 2.8 2.7 2.3 3.0 2.9
Pain Relievers 2.0 1.9 1.0 1.2 2.1 2.0 1.2 1.2 2.2 2.1
Stimulants 0.6 0.6 1.0 0.9 0.6 0.6 1.4a 0.9 0.5 0.5
Tranquilizers or Sedatives 0.8 0.8 0.5 0.5 0.9 0.8 0.8 0.7 0.9 0.8
Tranquilizers 0.6 0.6 0.3 0.3 0.7 0.6 0.7 0.5 0.7 0.7
Sedatives 0.3 0.3 0.2 0.3 0.3 0.3 0.2 0.2 0.3 0.3
Opioids 2.2 2.0 1.0 1.2 2.3 2.1 1.2 1.2 2.5 2.2
Central Nervous System Stimulants 1.6 1.5 1.0 1.0 1.7 1.6 2.2b 1.5 1.6 1.6
ALCOHOL 10.5 10.2 2.9 2.9 11.2 10.9 16.4a 15.1 10.4 10.3
BOTH DRUGS AND ALCOHOL 2.9 2.7 1.3 1.3 3.0 2.8 7.2b 5.9 2.4 2.3
DRUGS ONLY (NO ALCOHOL USE DISORDER) 6.8 6.9 5.7 5.5 6.9 7.1 11.4 12.1 6.2 6.3
ALCOHOL ONLY (NO DRUG USE DISORDER) 7.6 7.5 1.6 1.6 8.2 8.1 9.2 9.2 8.1 8.0
NO SUBSTANCE USE DISORDER 82.7 82.9 91.3 91.5 81.9 82.0 72.2 72.9 83.4 83.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.2A – Substance Use Disorder Severity Level for Specific Substances in Past Year: Among People Aged 12 or Older; Numbers in Thousands, 2022 and 2023
Substance Any
Substance Use
Disorder
(2022)		 Any
Substance Use
Disorder
(2023)		 Severity Level
Mild
Substance Use
Disorder
(2022)		 Mild
Substance Use
Disorder
(2023)		 Moderate
Substance Use
Disorder
(2022)		 Moderate
Substance Use
Disorder
(2023)		 Severe
Substance Use
Disorder
(2022)		 Severe
Substance Use
Disorder
(2023)
SUBSTANCE USE DISORDER 48,722 48,464 26,812 27,075 11,025 10,980 10,886 10,409
DRUGS 27,230 27,153 15,019 15,187 6,403 6,230 5,809 5,736
Marijuana 18,976 19,164 10,460 10,625 5,234 5,088 3,282 3,450
Cocaine 1,435 1,256 555 423 209 307 671 526
Heroin 900a 587 182 76 169 57 549 455
Hallucinogens 592 428 392 321 122 85 78a 22
Inhalants 332 304 257 200 39 24 36 80
Methamphetamine 1,826 1,784 544 495 392 285 890 1,004
Prescription Psychotherapeutics 8,227 7,889 5,580 5,512 1,093 1,320 1,554b 1,057
Pain Relievers 5,577 5,344 3,872 3,790 706 852 999 702
Stimulants 1,828 1,718 1,196 1,238 278 267 353a 213
Tranquilizers or Sedatives 2,355 2,256 1,515 1,469 356 440 485 347
Tranquilizers 1,807 1,747 1,235 1,102 205a 371 367 274
Sedatives 833 869 482 614 183 138 168 118
Opioids 6,117 5,679 3,866 3,724 828 898 1,423 1,056
Central Nervous System Stimulants 4,515 4,322 1,975 1,952 802 729 1,738 1,641
ALCOHOL 29,542 28,859 17,444 16,925 5,968 6,322 6,129 5,613
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.2B – Substance Use Disorder Severity Level for Specific Substances in Past Year: Among People Aged 12 or Older; Percentages, 2022 and 2023
Substance Any
Substance Use
Disorder
(2022)		 Any
Substance Use
Disorder
(2023)		 Severity Level
Mild
Substance Use
Disorder
(2022)		 Mild
Substance Use
Disorder
(2023)		 Moderate
Substance Use
Disorder
(2022)		 Moderate
Substance Use
Disorder
(2023)		 Severe
Substance Use
Disorder
(2022)		 Severe
Substance Use
Disorder
(2023)
SUBSTANCE USE DISORDER 17.3 17.1 9.5 9.6 3.9 3.9 3.9 3.7
DRUGS 9.7 9.6 5.3 5.4 2.3 2.2 2.1 2.0
Marijuana 6.7 6.8 3.7 3.7 1.9 1.8 1.2 1.2
Cocaine 0.5 0.4 0.2 0.1 0.1 0.1 0.2 0.2
Heroin 0.3a 0.2 0.1 <0.1 0.1 <0.1 0.2 0.2
Hallucinogens 0.2 0.2 0.1 0.1 <0.1 <0.1 <0.1a <0.1
Inhalants 0.1 0.1 0.1 0.1 <0.1 <0.1 <0.1 <0.1
Methamphetamine 0.6 0.6 0.2 0.2 0.1 0.1 0.3 0.4
Prescription Psychotherapeutics 2.9 2.8 2.0 1.9 0.4 0.5 0.6b 0.4
Pain Relievers 2.0 1.9 1.4 1.3 0.3 0.3 0.4 0.2
Stimulants 0.6 0.6 0.4 0.4 0.1 0.1 0.1a 0.1
Tranquilizers or Sedatives 0.8 0.8 0.5 0.5 0.1 0.2 0.2 0.1
Tranquilizers 0.6 0.6 0.4 0.4 0.1a 0.1 0.1 0.1
Sedatives 0.3 0.3 0.2 0.2 0.1 <0.1 0.1 <0.1
Opioids 2.2 2.0 1.4 1.3 0.3 0.3 0.5 0.4
Central Nervous System Stimulants 1.6 1.5 0.7 0.7 0.3 0.3 0.6 0.6
ALCOHOL 10.5 10.2 6.2 6.0 2.1 2.2 2.2 2.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.3A – Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category Drug Use Disorder
(2022)		 Drug Use Disorder
(2023)		 Alcohol Use Disorder
(2022)		 Alcohol Use Disorder
(2023)		 Substance Use
Disorder
(2022)		 Substance Use
Disorder
(2023)
TOTAL 27,230 27,153 29,542 28,859 48,722 48,464
12-201 4,041 3,869 2,215 2,109 5,188 5,082
21 or Older1 23,189 23,284 27,326 26,750 43,534 43,381
12-17 1,813 1,780 753 757 2,228 2,192
12-13 262 196 96a 37 329a 219
14-15 639 646 209 272 746 789
16-17 912 938 448 448 1,152 1,183
18 or Older 25,417 25,373 28,788 28,103 46,494 46,272
18-25 6,482 6,113 5,689a 5,123 9,669 9,228
18-20 2,228 2,089 1,462 1,353 2,960 2,891
21-25 4,254 4,024 4,227 3,770 6,709 6,337
26 or Older 18,935 19,260 23,099 22,980 36,825 37,044
26-49 12,597 12,559 14,618 14,585 23,186 23,295
26-29 2,911 2,981 3,055 2,908 4,902 4,901
30-34 3,263 2,994 3,649 3,646 5,666 5,621
35-39 2,479 2,811 3,038 3,023 4,826 5,065
40-44 2,118 1,918 2,678 2,837 4,146 4,216
45-49 1,826 1,855 2,199 2,171 3,645 3,493
50 or Older 6,338 6,701 8,481 8,395 13,639 13,748
50-54 1,584 1,547 2,485 1,934 3,616 3,089
55-59 1,398 1,259 1,973 1,837 3,081 2,872
60-64 1,523 1,661 1,679 1,942 3,013 3,176
65 or Older 1,833 2,235 2,344 2,682 3,929 4,610
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.3B – Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category Drug Use Disorder
(2022)		 Drug Use Disorder
(2023)		 Alcohol Use Disorder
(2022)		 Alcohol Use Disorder
(2023)		 Substance Use
Disorder
(2022)		 Substance Use
Disorder
(2023)
TOTAL 9.7 9.6 10.5 10.2 17.3 17.1
12-201 10.5 10.2 5.7 5.5 13.4 13.4
21 or Older1 9.5 9.5 11.2 10.9 17.9 17.7
12-17 7.0 6.9 2.9 2.9 8.7 8.5
12-13 3.1 2.5 1.1a 0.5 3.9 2.8
14-15 7.1 7.1 2.3 3.0 8.2 8.6
16-17 11.1 10.6 5.4 5.1 14.0 13.4
18 or Older 9.9 9.9 11.2 10.9 18.1 18.0
18-25 18.6 18.0 16.4a 15.1 27.8 27.1
18-20 17.2 17.2 11.3 11.1 22.9 23.8
21-25 19.5 18.4 19.3a 17.2 30.7 29.0
26 or Older 8.5 8.6 10.4 10.3 16.6 16.6
26-49 12.3 12.1 14.3 14.1 22.6 22.5
26-29 17.1 16.9 17.9 16.5 28.8 27.9
30-34 14.1 13.2 15.7 16.1 24.4 24.8
35-39 11.2 12.1 13.8 13.0 21.9 21.8
40-44 10.2 9.0 12.9 13.4 19.9 19.9
45-49 9.4 9.8 11.3 11.5 18.7 18.5
50 or Older 5.3 5.6 7.1 7.0 11.5 11.5
50-54 8.0 8.3 12.6 10.4 18.3 16.5
55-59 7.0 6.1 9.9 8.9 15.4 14.0
60-64 6.7 7.3 7.4 8.5 13.3 13.9
65 or Older 3.2 3.9 4.1 4.6 7.0 8.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.4A – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 27,230 27,153 1,813 1,780 25,417 25,373 6,482 6,113 18,935 19,260
SEX                    
Male 15,096 15,375 819 680 14,277 14,695 3,407 3,354 10,871 11,342
Female 12,134 11,778 994 1,100 11,140 10,678 3,075a 2,759 8,064 7,919
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 22,189 22,568 1,270 1,236 20,919 21,332 5,001 4,774 15,918 16,558
AIAN 253 263 20 14 233 249 * * 174 209
Asian 827 767 46 54 782 712 163 168 619 545
Black or African American 3,957 3,953 285 252 3,672 3,701 863 979 2,808 2,722
NHOPI * * * * * * * * * *
White 16,056 16,389 845 819 15,211 15,569 3,657 3,300 11,554 12,269
Two or More Races 921 934 68 95 853 839 226 271 627 568
Hispanic or Latino 5,041 4,585 542 544 4,498 4,041 1,481 1,339 3,017 2,702
EDUCATION LEVEL                    
< High School da da da da 2,835 2,884 760 723 2,075 2,161
High School Graduate da da da da 7,877 8,442 2,204 2,307 5,673 6,135
Some College/Associate’s Degree da da da da 9,212 8,885 2,617 2,412 6,595 6,474
College Graduate da da da da 5,494 5,162 901a 671 4,592 4,491
EMPLOYMENT STATUS                    
Full-Time da da da da 11,087 11,574 2,879 2,630 8,209 8,944
Part-Time da da da da 4,028 3,518 1,637 1,597 2,391 1,921
Unemployed da da da da 2,030 2,318 689 763 1,341 1,555
Other1 da da da da 8,272 7,964 1,277 1,124 6,995 6,840
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Drug use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.4B – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 9.7 9.6 7.0 6.9 9.9 9.9 18.6 18.0 8.5 8.6
SEX                    
Male 10.9 11.1 6.2 5.1 11.4 11.7 19.5 19.6 10.1 10.5
Female 8.4 8.1 7.9 8.7 8.5 8.1 17.8 16.3 7.1 6.9
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 9.6 9.8 6.7 6.5 9.9 10.1 18.9 18.5 8.6 8.9
AIAN 17.3 19.7 9.2 6.0 18.8 22.6 * * 16.9 21.7
Asian 4.9 4.4 2.8 3.7 5.1 4.4 7.2 7.6 4.7 3.9
Black or African American 11.5 11.4 8.1 7.0 11.9 11.9 18.5 21.5 10.7 10.2
NHOPI * * * * * * * * * *
White 9.4 9.6 6.6 6.4 9.6 9.9 20.0 18.7 8.3 8.8
Two or More Races 15.7 15.1 8.1 10.2 16.9 15.9 22.5 24.8 15.5 13.6
Hispanic or Latino 9.9 8.8 8.2 8.0 10.2 8.9 17.9 16.2 8.4 7.3
EDUCATION LEVEL                    
< High School da da da da 11.6 11.8 21.2 20.2 10.0 10.3
High School Graduate da da da da 11.4 12.2 19.0 20.0 9.9 10.6
Some College/Associate’s Degree da da da da 11.8 11.5 18.8 18.3 10.3 10.1
College Graduate da da da da 6.5 6.0 15.8b 11.7 5.8 5.6
EMPLOYMENT STATUS                    
Full-Time da da da da 9.4 9.6 20.5 19.0 7.9 8.3
Part-Time da da da da 12.3 11.2 18.6 19.1 9.9 8.3
Unemployed da da da da 18.4 20.3 21.5 22.8 17.2 19.2
Other1 da da da da 8.8 8.5 14.7 13.2 8.2 8.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Drug use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.5A – Marijuana Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 18,976 19,164 1,308 1,223 17,669 17,941 5,740 5,634 11,928 12,308
SEX                    
Male 11,033 11,380 586 474 10,447 10,906 3,077 3,116 7,369 7,790
Female 7,943 7,784 721 748 7,222 7,035 2,663 2,518 4,559 4,518
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 15,330 15,948 892 827 14,438 15,121 4,381 4,407 10,057 10,714
AIAN 161 173 17 10 144 163 * * 89 134
Asian 560 374 27 35 533 339 141 149 392 190
Black or African American 2,772 3,020 208 179 2,564 2,841 792 950 1,772 1,890
NHOPI 113 * * * 107 * * * * *
White 10,982 11,495 582 527 10,400 10,968 3,150 3,018 7,250 7,950
Two or More Races 742 778 53 74 689 704 210 247 479 457
Hispanic or Latino 3,647 3,216 416 396 3,231 2,820 1,359 1,227 1,872 1,593
EDUCATION LEVEL                    
< High School da da da da 1,802 1,775 671 648 1,132 1,127
High School Graduate da da da da 5,638 6,070 1,988 2,151 3,650 3,919
Some College/Associate’s Degree da da da da 6,451 6,458 2,327 2,214 4,124 4,244
College Graduate da da da da 3,778 3,638 755 620 3,023 3,019
EMPLOYMENT STATUS                    
Full-Time da da da da 8,743 8,993 2,579 2,454 6,164 6,540
Part-Time da da da da 2,977 2,853 1,457 1,461 1,521 1,392
Unemployed da da da da 1,501 1,726 584 714 917 1,012
Other1 da da da da 4,448 4,369 1,121 1,005 3,327 3,364
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Marijuana use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on marijuana use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.5B – Marijuana Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 6.7 6.8 5.1 4.7 6.9 7.0 16.5 16.6 5.4 5.5
SEX                    
Male 8.0 8.2 4.5 3.6 8.4 8.7 17.6 18.3 6.8 7.2
Female 5.5 5.4 5.7 5.9 5.5 5.3 15.4 14.8 4.0 3.9
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 6.6 6.9 4.7 4.3 6.8 7.1 16.5 17.1 5.4 5.8
AIAN 11.0 12.9 7.6 4.5 11.6 14.7 * * 8.6 13.9
Asian 3.3 2.1 1.7 2.4 3.5 2.1 6.2 6.7 3.0 1.4
Black or African American 8.0 8.7 5.9 5.0 8.3 9.1 17.0a 20.8 6.7 7.1
NHOPI 8.9 * * * 8.9 * * * * *
White 6.4 6.7 4.5 4.1 6.6 7.0 17.3 17.1 5.2 5.7
Two or More Races 12.6 12.6 6.4 8.0 13.6 13.4 20.9 22.6 11.8 11.0
Hispanic or Latino 7.2 6.2 6.3 5.8 7.3 6.2 16.5 14.9 5.2 4.3
EDUCATION LEVEL                    
< High School da da da da 7.4 7.3 18.7 18.1 5.4 5.4
High School Graduate da da da da 8.2 8.7 17.1 18.6 6.3 6.8
Some College/Associate’s Degree da da da da 8.3 8.4 16.8 16.8 6.5 6.6
College Graduate da da da da 4.4 4.2 13.3 10.8 3.8 3.7
EMPLOYMENT STATUS                    
Full-Time da da da da 7.4 7.4 18.3 17.7 5.9 6.1
Part-Time da da da da 9.1 9.0 16.6 17.5 6.3 6.0
Unemployed da da da da 13.6 15.1 18.2 21.4 11.7 12.5
Other1 da da da da 4.7 4.7 12.9 11.8 3.9 4.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Marijuana use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on marijuana use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.6A – Prescription Pain Reliever Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 5,577 5,344 265 316 5,312 5,027 410 392 4,902 4,636
SEX                    
Male 2,643 2,520 109 100 2,533 2,420 187 186 2,346 2,234
Female 2,934 2,824 156 216 2,779 2,608 224 206 2,555 2,402
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4,574 4,461 182 229 4,392 4,232 333 291 4,059 3,940
AIAN 91 48 1 1 * 47 * * * 38
Asian 186 305 9 22 177 283 6 10 171 272
Black or African American 910 735 52 42 858 693 64 53 794 640
NHOPI 53 * * * * * * * * *
White 3,175 3,166 106 155 3,069 3,011 233 193 2,836 2,818
Two or More Races 159 101 14 8 145 93 19 24 126 69
Hispanic or Latino 1,004 883 83 87 920 796 78 100 843 696
EDUCATION LEVEL                    
< High School da da da da 720 911 102 88 619 823
High School Graduate da da da da 1,811 1,766 143 119 1,668 1,646
Some College/Associate’s Degree da da da da 2,009 1,625 132 172 1,877 1,453
College Graduate da da da da 771 726 33 12 738 714
EMPLOYMENT STATUS                    
Full-Time da da da da 1,337 1,428 158 143 1,179 1,286
Part-Time da da da da 621 440 69 93 552 346
Unemployed da da da da 339 360 67 44 272 316
Other1 da da da da 3,014 2,800 117 112 2,898 2,688
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Prescription pain reliever use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on prescription pain reliever use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.6B – Prescription Pain Reliever Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 2.0 1.9 1.0 1.2 2.1 2.0 1.2 1.2 2.2 2.1
SEX                    
Male 1.9 1.8 0.8 0.8 2.0 1.9 1.1 1.1 2.2 2.1
Female 2.0 1.9 1.2 1.7 2.1 2.0 1.3 1.2 2.2 2.1
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.0 1.9 1.0 1.2 2.1 2.0 1.3 1.1 2.2 2.1
AIAN 6.2 3.6 0.7 0.6 * 4.2 * * * 4.0
Asian 1.1 1.7 0.5 1.5 1.1 1.8 0.3 0.5 1.3 2.0
Black or African American 2.6 2.1 1.5 1.2 2.8 2.2 1.4 1.2 3.0 2.4
NHOPI 4.2 * * * * * * * * *
White 1.9 1.9 0.8 1.2 1.9 1.9 1.3 1.1 2.0 2.0
Two or More Races 2.7 1.6 1.7 0.9 2.9 1.8 1.9 2.2 3.1 1.7
Hispanic or Latino 2.0 1.7 1.3 1.3 2.1 1.8 0.9 1.2 2.3 1.9
EDUCATION LEVEL                    
< High School da da da da 3.0 3.7 2.8 2.5 3.0 3.9
High School Graduate da da da da 2.6 2.5 1.2 1.0 2.9 2.8
Some College/Associate’s Degree da da da da 2.6 2.1 1.0 1.3 2.9 2.3
College Graduate da da da da 0.9 0.8 0.6 0.2 0.9 0.9
EMPLOYMENT STATUS                    
Full-Time da da da da 1.1 1.2 1.1 1.0 1.1 1.2
Part-Time da da da da 1.9 1.4 0.8 1.1 2.3 1.5
Unemployed da da da da 3.1 3.1 2.1 1.3 3.5 3.9
Other1 da da da da 3.2 3.0 1.3 1.3 3.4 3.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Prescription pain reliever use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on prescription pain reliever use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.7A – Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 6,117 5,679 265 316 5,852 5,363 424 396 5,427 4,967
SEX                    
Male 3,054 2,697 109 100 2,944 2,597 198 187 2,747 2,409
Female 3,063 2,982 156 216 2,907 2,766 227 208 2,680 2,558
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 5,073 4,713 182 229 4,891 4,483 345 295 4,547 4,188
AIAN 96 52 1 1 95 50 * * * 42
Asian 206 305 9 22 197 283 6 10 191 272
Black or African American 1,043 781 52 42 992 739 64 53 928 685
NHOPI 68 * * * 67 * * * * *
White 3,486 3,350 106 155 3,380 3,195 243 197 3,138 2,999
Two or More Races 174 105 14 8 161 97 21 24 140 73
Hispanic or Latino 1,043 966 83 87 960 879 79 100 881 779
EDUCATION LEVEL                    
< High School da da da da 831 959 103 89 728 870
High School Graduate da da da da 2,007 1,920 149 121 1,858 1,800
Some College/Associate’s Degree da da da da 2,205 1,730 139 174 2,065 1,556
College Graduate da da da da 809 753 33 12 776 741
EMPLOYMENT STATUS                    
Full-Time da da da da 1,459 1,575 160 145 1,299 1,430
Part-Time da da da da 659 461 72 93 587 368
Unemployed da da da da 449 372 73 44 375 328
Other1 da da da da 3,285 2,954 119 113 3,166 2,841
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Opioid use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.7B – Opioid Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 2.2 2.0 1.0 1.2 2.3 2.1 1.2 1.2 2.5 2.2
SEX                    
Male 2.2 1.9 0.8 0.8 2.4 2.1 1.1 1.1 2.6 2.2
Female 2.1 2.1 1.2 1.7 2.2 2.1 1.3 1.2 2.4 2.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.2 2.0 1.0 1.2 2.3 2.1 1.3 1.1 2.5 2.2
AIAN 6.6 3.8 0.7 0.6 7.6 4.5 * * * 4.3
Asian 1.2 1.7 0.5 1.5 1.3 1.8 0.3 0.5 1.5 2.0
Black or African American 3.0 2.2 1.5 1.2 3.2 2.4 1.4 1.2 3.5 2.6
NHOPI 5.3 * * * 5.6 * * * * *
White 2.0 2.0 0.8 1.2 2.1 2.0 1.3 1.1 2.2 2.1
Two or More Races 3.0 1.7 1.7 0.9 3.2 1.8 2.1 2.2 3.5 1.7
Hispanic or Latino 2.0 1.8 1.3 1.3 2.2 1.9 1.0 1.2 2.4 2.1
EDUCATION LEVEL                    
< High School da da da da 3.4 3.9 2.9 2.5 3.5 4.2
High School Graduate da da da da 2.9 2.8 1.3 1.0 3.2 3.1
Some College/Associate’s Degree da da da da 2.8 2.2 1.0 1.3 3.2a 2.4
College Graduate da da da da 1.0 0.9 0.6 0.2 1.0 0.9
EMPLOYMENT STATUS                    
Full-Time da da da da 1.2 1.3 1.1 1.1 1.2 1.3
Part-Time da da da da 2.0 1.5 0.8 1.1 2.4 1.6
Unemployed da da da da 4.1 3.3 2.3 1.3 4.8 4.0
Other1 da da da da 3.5 3.2 1.4 1.3 3.7 3.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Opioid use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.8A – Central Nervous System Stimulant Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 4,515 4,322 267 268 4,247 4,053 755b 525 3,492 3,529
SEX                    
Male 2,765 2,502 139 123 2,626 2,379 380 268 2,245 2,111
Female 1,750 1,820 128 145 1,622 1,674 375a 256 1,247 1,418
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 3,724 3,636 221 194 3,503 3,442 591 447 2,912 2,996
AIAN 30 74 * 3 28 72 * 6 22 66
Asian 134 75 5 5 129 71 30 21 99 50
Black or African American 402 365 29 11 372 354 49 21 323 333
NHOPI * * * * * * * * * *
White 2,936 2,954 171 161 2,765 2,793 493 378 2,272 2,414
Two or More Races 135 111 13 13 121 97 12 20 109 77
Hispanic or Latino 791 686 46 75 745 611 164a 78 581 533
EDUCATION LEVEL                    
< High School da da da da 654 540 111 82 542 457
High School Graduate da da da da 1,177 1,235 193 176 984 1,059
Some College/Associate’s Degree da da da da 1,654 1,455 301 200 1,353 1,255
College Graduate da da da da 763 824 150b 66 613 758
EMPLOYMENT STATUS                    
Full-Time da da da da 1,690 1,755 349b 209 1,341 1,546
Part-Time da da da da 633 524 159 147 474 377
Unemployed da da da da 550 524 98 68 452 456
Other1 da da da da 1,374 1,250 149 101 1,225 1,149
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Central nervous system stimulant use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on central nervous system stimulant use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.8B – Central Nervous System Stimulant Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 1.6 1.5 1.0 1.0 1.7 1.6 2.2b 1.5 1.6 1.6
SEX                    
Male 2.0 1.8 1.1 0.9 2.1 1.9 2.2 1.6 2.1 1.9
Female 1.2 1.3 1.0 1.1 1.2 1.3 2.2a 1.5 1.1 1.2
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 1.6 1.6 1.2 1.0 1.7 1.6 2.2 1.7 1.6 1.6
AIAN 2.1 5.5 * 1.2 2.2 6.5 * 4.1 2.2 6.8
Asian 0.8 0.4 0.3 0.3 0.8 0.4 1.3 1.0 0.8 0.4
Black or African American 1.2 1.1 0.8 0.3 1.2 1.1 1.1 0.5 1.2 1.3
NHOPI * * * * * * * * * *
White 1.7 1.7 1.3 1.3 1.7 1.8 2.7 2.1 1.6 1.7
Two or More Races 2.3 1.8 1.6 1.4 2.4 1.8 1.2 1.9 2.7 1.8
Hispanic or Latino 1.6 1.3 0.7 1.1 1.7 1.3 2.0a 0.9 1.6 1.4
EDUCATION LEVEL                    
< High School da da da da 2.7 2.2 3.1 2.3 2.6 2.2
High School Graduate da da da da 1.7 1.8 1.7 1.5 1.7 1.8
Some College/Associate’s Degree da da da da 2.1 1.9 2.2 1.5 2.1 2.0
College Graduate da da da da 0.9 1.0 2.6b 1.1 0.8 0.9
EMPLOYMENT STATUS                    
Full-Time da da da da 1.4 1.5 2.5b 1.5 1.3 1.4
Part-Time da da da da 1.9 1.7 1.8 1.8 2.0 1.6
Unemployed da da da da 5.0 4.6 3.0 2.0 5.8 5.6
Other1 da da da da 1.5 1.3 1.7 1.2 1.4 1.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Central nervous system stimulant use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on central nervous system stimulant use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.9A – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)		 Aged 12-201
(2022)		 Aged 12-201
(2023)		 Aged 21+1
(2022)		 Aged 21+1
(2023)
TOTAL 29,542 28,859 753 757 28,788 28,103 5,689a 5,123 23,099 22,980 2,215 2,109 27,326 26,750
SEX                            
Male 17,351 16,838 281 270 17,070 16,568 2,984b 2,557 14,085 14,011 1,033 938 16,318 15,899
Female 12,191 12,022 472 487 11,719 11,535 2,705 2,566 9,014 8,969 1,182 1,171 11,009 10,851
HISPANIC ORIGIN AND RACE                            
Not Hispanic or Latino 24,055 24,054 528 533 23,527 23,521 4,317a 3,934 19,210 19,587 1,659 1,623 22,396 22,431
AIAN 154 156 10 5 143 150 29 * 114 126 23 11 131 145
Asian 958 994 28 15 929 979 199 263 730 716 62 86 896 908
Black or African American 3,609 3,323 55 46 3,555 3,277 532 571 3,023 2,705 173 208 3,436 3,115
NHOPI * 88 * * * 87 * * * 68 * * * 87
White 18,582 18,652 406 438 18,176 18,214 3,365a 2,856 14,811 15,358 1,297 1,208 17,285 17,444
Two or More Races 609a 841 29 28 580a 813 158 201 422 613 103 109 506a 732
Hispanic or Latino 5,486 4,805 225 223 5,261 4,582 1,372 1,188 3,889 3,393 556 486 4,930 4,319
EDUCATION LEVEL                            
< High School da da da da 2,322 2,358 447 455 1,876 1,903 da da 2,082 2,146
High School Graduate da da da da 6,999 6,952 1,641 1,522 5,358 5,430 da da 6,385 6,456
Some College/Associate’s Degree da da da da 9,608 8,813 2,378 2,176 7,230 6,637 da da 9,001 8,169
College Graduate da da da da 9,859 9,980 1,223a 970 8,636 9,010 da da 9,858 9,979
EMPLOYMENT STATUS                            
Full-Time da da da da 16,682 16,016 2,819b 2,340 13,863 13,675 da da 16,141 15,625
Part-Time da da da da 4,050 3,717 1,357 1,320 2,693 2,397 da da 3,549 3,269
Unemployed da da da da 1,704 1,760 473 546 1,231 1,215 da da 1,571 1,634
Other2 da da da da 6,352 6,610 1,039 917 5,313 5,693 da da 6,065 6,222
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol.
2 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.9B – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)		 Aged 12-201
(2022)		 Aged 12-201
(2023)		 Aged 21+1
(2022)		 Aged 21+1
(2023)
TOTAL 10.5 10.2 2.9 2.9 11.2 10.9 16.4a 15.1 10.4 10.3 5.7 5.5 11.2 10.9
SEX                            
Male 12.6 12.1 2.1 2.0 13.6 13.2 17.1a 15.0 13.1 12.9 5.2 4.8 13.8 13.4
Female 8.5 8.3 3.8 3.8 8.9 8.7 15.6 15.1 7.9 7.8 6.3 6.3 8.8 8.6
HISPANIC ORIGIN AND RACE                            
Not Hispanic or Latino 10.4 10.4 2.8 2.8 11.1 11.1 16.3 15.3 10.4 10.5 5.8 5.8 11.1 11.0
AIAN 10.5 11.6 4.7 2.3 11.5 13.6 14.0 * 11.0 13.1 7.1 3.7 11.5 13.8
Asian 5.6 5.7 1.8 1.0 6.0 6.1 8.8 11.9 5.6 5.2 2.5 3.6 6.1 6.0
Black or African American 10.5 9.6 1.6 1.3 11.5 10.5 11.4 12.5 11.5 10.2 3.3 4.0 11.8 10.6
NHOPI * 7.9 * * * 8.5 * * * 7.6 * * * 8.8
White 10.9 11.0 3.2 3.4 11.5 11.6 18.4a 16.2 10.6 11.0 6.7 6.4 11.4 11.5
Two or More Races 10.4 13.6 3.5 3.0 11.5 15.4 15.7 18.4 10.4 14.7 8.0 8.1 11.0 15.1
Hispanic or Latino 10.8a 9.2 3.4 3.3 11.9a 10.1 16.6 14.4 10.8 9.1 5.6 4.9 12.0a 10.2
EDUCATION LEVEL                            
< High School da da da da 9.5 9.6 12.5 12.7 9.0 9.1 da da 9.4 9.7
High School Graduate da da da da 10.1 10.0 14.1 13.2 9.3 9.4 da da 10.1 10.1
Some College/Associate’s Degree da da da da 12.4 11.4 17.1 16.5 11.3 10.4 da da 12.3 11.3
College Graduate da da da da 11.6 11.5 21.5b 16.9 10.9 11.2 da da 11.6 11.5
EMPLOYMENT STATUS                            
Full-Time da da da da 14.1 13.2 20.0b 16.9 13.3 12.8 da da 14.1 13.2
Part-Time da da da da 12.3 11.8 15.4 15.8 11.2 10.3 da da 12.4 11.8
Unemployed da da da da 15.5 15.4 14.7 16.3 15.8 15.0 da da 16.2 16.3
Other2 da da da da 6.8 7.1 11.9 10.8 6.2 6.7 da da 6.7 6.9
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol.
2 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.10A – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 48,722 48,464 2,228 2,192 46,494 46,272 9,669 9,228 36,825 37,044
SEX                    
Male 27,658 27,735 980 852 26,678 26,883 5,051 4,857 21,627 22,026
Female 21,064 20,729 1,249 1,340 19,816 19,389 4,618 4,371 15,198 15,018
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 39,841 40,276 1,561 1,520 38,280 38,755 7,408 7,134 30,872 31,621
AIAN 351 339 27 17 324 321 * * 245 265
Asian 1,532 1,608 58 58 1,475 1,549 297 372 1,178 1,177
Black or African American 6,324 6,116 313 264 6,011 5,851 1,114 1,269 4,897 4,582
NHOPI * * * * * * * * * *
White 30,071 30,382 1,074 1,075 28,997 29,306 5,576 5,041 23,421 24,265
Two or More Races 1,280 1,505 84 103 1,196 1,402 302 363 894 1,039
Hispanic or Latino 8,881 8,188 667 671 8,214 7,517 2,261 2,094 5,953 5,423
EDUCATION LEVEL                    
< High School da da da da 4,332 4,534 955 968 3,377 3,566
High School Graduate da da da da 12,642 13,189 3,067 3,126 9,575 10,062
Some College/Associate’s Degree da da da da 15,865 14,959 3,955 3,724 11,910 11,235
College Graduate da da da da 13,655 13,591 1,692a 1,410 11,963 12,181
EMPLOYMENT STATUS                    
Full-Time da da da da 23,825 23,909 4,486 4,126 19,339 19,784
Part-Time da da da da 6,744 6,204 2,403 2,390 4,341 3,814
Unemployed da da da da 3,070 3,306 908 1,017 2,162 2,289
Other1 da da da da 12,855 12,853 1,872 1,696 10,983 11,157
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.10B – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 17.3 17.1 8.7 8.5 18.1 18.0 27.8 27.1 16.6 16.6
SEX                    
Male 20.0 20.0 7.4 6.4 21.3 21.4 28.9 28.5 20.1 20.3
Female 14.7 14.3 9.9 10.6 15.1 14.7 26.7 25.8 13.3 13.0
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 17.2 17.4 8.2 8.0 18.1 18.3 27.9 27.7 16.6 17.0
AIAN 24.0 25.3 12.1 7.4 26.1 29.1 * * 23.8 27.5
Asian 9.0 9.2 3.6 4.0 9.6 9.7 13.1 16.8 9.0 8.5
Black or African American 18.4 17.6 8.9 7.3 19.4 18.8 23.9 27.8 18.6 17.2
NHOPI * * * * * * * * * *
White 17.6 17.8 8.4 8.4 18.3 18.6 30.5 28.6 16.7 17.3
Two or More Races 21.8 24.3 10.1 11.1 23.7 26.6 30.1 33.2 22.1 24.9
Hispanic or Latino 17.4a 15.7 10.0 9.9 18.6a 16.5 27.4 25.4 16.5 14.6
EDUCATION LEVEL                    
< High School da da da da 17.8 18.5 26.6 27.1 16.3 17.1
High School Graduate da da da da 18.3 19.0 26.4 27.1 16.6 17.4
Some College/Associate’s Degree da da da da 20.4 19.4 28.5 28.3 18.6 17.6
College Graduate da da da da 16.1 15.7 29.7b 24.5 15.1 15.1
EMPLOYMENT STATUS                    
Full-Time da da da da 20.1 19.8 31.9 29.8 18.5 18.5
Part-Time da da da da 20.5 19.7 27.3 28.6 18.1 16.4
Unemployed da da da da 27.9 28.9 28.3 30.4 27.7 28.3
Other1 da da da da 13.7 13.7 21.5 19.9 12.9 13.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.11A – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 27,230 27,153 1,813 1,780 25,417 25,373 6,482 6,113 18,935 19,260
GEOGRAPHIC REGION                    
Northeast 4,324a 5,099 221 285 4,103a 4,814 1,025 1,145 3,079 3,670
Midwest 5,746 5,615 381 378 5,364 5,237 1,391 1,327 3,973 3,910
South 9,563 9,458 702 678 8,861 8,780 2,263 2,047 6,598 6,733
West 7,597 6,981 508 439 7,088 6,542 1,803 1,594 5,285 4,948
COUNTY TYPE                    
Large Metro 14,733 14,571 997 983 13,736 13,587 3,535 3,089 10,202 10,499
Small Metro 9,165 8,886 665 610 8,499 8,275 2,292 2,239 6,208 6,037
Nonmetro 3,332 3,697 151 186 3,181 3,510 656 785 2,526 2,725
Urbanized 1,490 1,553 82 70 1,407 1,484 322 396 1,086 1,088
Less Urbanized 1,541 1,914 47a 93 1,494 1,821 316 353 1,178 1,468
Completely Rural 301 229 * 24 280 206 18 37 262 169
POVERTY LEVEL1                    
Less Than 100% 5,919 6,234 341 357 5,578 5,877 1,484 1,423 4,094 4,455
100-199% 6,771 6,240 512 409 6,259 5,831 1,828 1,540 4,431 4,291
200% or More 14,540 14,669 960 1,014 13,580 13,655 3,169 3,141 10,410 10,515
HEALTH INSURANCE2                    
Private 12,938 13,115 884 934 12,054 12,181 3,631a 3,199 8,423 8,982
Medicaid/CHIP 9,578 9,298 876 838 8,702 8,460 1,886 2,009 6,816 6,451
Other3 5,374 5,424 109 96 5,266 5,328 524 542 4,742 4,787
No Coverage 2,984 3,265 55 50 2,929 3,215 756 723 2,173 2,492
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Drug use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.11B – Drug Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 9.7 9.6 7.0 6.9 9.9 9.9 18.6 18.0 8.5 8.6
GEOGRAPHIC REGION                    
Northeast 8.8a 10.4 5.4 7.0 9.1a 10.7 17.3 19.9 7.9 9.4
Midwest 9.9 9.6 7.1 7.0 10.2 9.9 19.1 18.6 8.7 8.6
South 8.8 8.7 6.9 6.6 9.0 8.9 17.0 15.6 7.8 7.8
West 11.4 10.4 8.3 7.1 11.7 10.8 21.9 19.8 10.1 9.4
COUNTY TYPE                    
Large Metro 9.4 9.3 6.7 6.9 9.7 9.5 18.5 16.8 8.4 8.4
Small Metro 10.3 10.0 8.3 7.4 10.4 10.3 19.6 19.6 8.9 8.7
Nonmetro 9.1 9.8 5.1 5.5 9.4 10.3 16.5 18.4 8.5 9.1
Urbanized 9.6 10.2 6.6 5.7 9.9 10.6 18.3 21.0 8.7 9.0
Less Urbanized 8.4 9.9 3.3 5.0 8.8 10.4 16.1 16.9 7.8 9.5
Completely Rural 10.6 7.4 * 7.7 10.9 7.3 7.0 12.7 11.3 6.7
POVERTY LEVEL1                    
Less Than 100% 14.3 13.8 6.5 6.2 15.4 14.9 18.4 16.9 14.5 14.4
100-199% 12.2 11.5 8.8 7.6 12.6 11.9 21.6 19.6 10.7 10.4
200% or More 7.9 8.0 6.5 6.8 8.0 8.1 17.4 17.7 6.8 6.9
HEALTH INSURANCE2                    
Private 7.6 7.7 6.3 6.7 7.7 7.8 18.3 16.8 6.2 6.5
Medicaid/CHIP 16.3 15.3 8.2 7.7 18.1 17.0 20.3 21.1 17.6 16.0
Other3 6.9 6.9 7.2 6.9 6.9 6.9 18.7 19.2 6.4 6.4
No Coverage 12.3 13.7 5.5 4.0 12.6 14.3 16.3 16.1 11.7 13.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Drug use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on drug use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.12A – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)		 Aged 12-201
(2022)		 Aged 12-201
(2023)		 Aged 21+1
(2022)		 Aged 21+1
(2023)
TOTAL 29,542 28,859 753 757 28,788 28,103 5,689a 5,123 23,099 22,980 2,215 2,109 27,326 26,750
GEOGRAPHIC REGION                            
Northeast 5,167 5,159 113 115 5,053 5,044 995 948 4,058 4,096 385 348 4,782 4,811
Midwest 6,405 6,091 137 187 6,268 5,904 1,227 1,130 5,042 4,774 480 473 5,925 5,618
South 10,049 10,820 302 264 9,746 10,556 1,888 1,871 7,858 8,685 795 767 9,254 10,053
West 7,921a 6,789 200 191 7,720a 6,598 1,578b 1,173 6,142 5,425 556 521 7,365 6,269
COUNTY TYPE                            
Large Metro 16,720 16,422 393 349 16,326 16,073 3,092 2,803 13,234 13,270 1,131 1,057 15,589 15,365
Small Metro 9,559 9,418 257 301 9,301 9,117 1,946 1,751 7,355 7,366 783 773 8,775 8,645
Nonmetro 3,263 3,020 103 107 3,161 2,913 651 569 2,510 2,344 301 279 2,963 2,741
Urbanized 1,446 1,281 40 44 1,406 1,237 274 255 1,132 982 128 123 1,318 1,158
Less Urbanized 1,605 1,532 48 56 1,557 1,476 351 278 1,206 1,198 152 141 1,453 1,391
Completely Rural 212 207 * 7 197 200 * 36 172 164 * 15 191 193
POVERTY LEVEL2                            
Less Than 100% 4,375 4,302 140 148 4,235 4,154 1,319 1,247 2,915 2,907 536 567 3,839 3,735
100-199% 5,252 4,802 176 144 5,076 4,658 1,262 1,165 3,814 3,493 413 361 4,839 4,442
200% or More 19,913 19,749 438 464 19,476 19,285 3,105a 2,705 16,370 16,580 1,264 1,176 18,649 18,574
HEALTH INSURANCE3                            
Private 18,460 17,819 398 417 18,062 17,402 3,660a 3,164 14,402 14,237 1,286 1,243 17,174 16,576
Medicaid/CHIP 5,756 5,836 298 309 5,458 5,526 1,241 1,196 4,217 4,331 703 678 5,053 5,158
Other4 5,159 5,212 76 42 5,084 5,170 391 421 4,692 4,749 168 179 4,992 5,033
No Coverage 3,229 3,095 42 31 3,188 3,064 630 636 2,557 2,428 168 144 3,061 2,951
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.12B – Alcohol Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)		 Aged 12-201
(2022)		 Aged 12-201
(2023)		 Aged 21+1
(2022)		 Aged 21+1
(2023)
TOTAL 10.5 10.2 2.9 2.9 11.2 10.9 16.4a 15.1 10.4 10.3 5.7 5.5 11.2 10.9
GEOGRAPHIC REGION                            
Northeast 10.5 10.5 2.8 2.8 11.2 11.2 16.8 16.5 10.4 10.5 6.2 5.8 11.2 11.2
Midwest 11.0 10.5 2.5 3.4 11.9 11.2 16.8 15.8 11.1 10.5 5.9 5.8 11.8 11.2
South 9.3 9.9 3.0 2.6 9.9 10.7 14.2 14.3 9.3 10.1 5.2 5.2 10.0 10.6
West 11.9a 10.1 3.3 3.1 12.7a 10.8 19.2b 14.6 11.7 10.3 6.0 5.7 12.8a 10.8
COUNTY TYPE                            
Large Metro 10.7 10.5 2.7 2.4 11.6 11.3 16.2 15.3 10.8 10.7 5.2 5.1 11.6 11.3
Small Metro 10.7 10.6 3.2 3.6 11.4 11.3 16.6 15.3 10.6 10.6 6.3 6.2 11.4 11.3
Nonmetro 8.9 8.0 3.5 3.1 9.3 8.5 16.3 13.4 8.4 7.8 6.7 5.6 9.2 8.4
Urbanized 9.3 8.4 3.3 3.6 9.9 8.9 15.5 13.5 9.1 8.1 6.7 6.4 9.7 8.7
Less Urbanized 8.7 7.9 3.4 3.0 9.2 8.4 17.8 13.3 8.0 7.8 7.0 5.3 9.0 8.3
Completely Rural 7.4 6.7 * 2.2 7.7 7.1 * 12.2 7.4 6.6 * 3.8 7.7 7.1
POVERTY LEVEL2                            
Less Than 100% 10.5 9.5 2.7 2.6 11.7 10.5 16.4 14.8 10.4 9.4 6.3 6.3 11.7 10.3
100-199% 9.4 8.8 3.0 2.7 10.2 9.5 14.9 14.8 9.2 8.5 4.7 4.5 10.4 9.6
200% or More 10.8 10.7 3.0 3.1 11.4 11.4 17.0 15.3 10.8 11.0 6.0 5.6 11.4 11.4
HEALTH INSURANCE3                            
Private 10.9 10.4 2.8 3.0 11.6 11.1 18.4 16.6 10.6 10.3 6.2 6.1 11.5 11.0
Medicaid/CHIP 9.8 9.6 2.8 2.8 11.4 11.1 13.4 12.5 10.9 10.7 4.7 4.5 11.5 11.3
Other4 6.6 6.6 5.0 3.0 6.6 6.7 13.9 14.9 6.3 6.4 6.4 7.4 6.6 6.6
No Coverage 13.3 13.0 4.2 2.5 13.7 13.6 13.6 14.2 13.7 13.5 6.6 5.5 14.1 14.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Alcohol use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The aged 12-20 and aged 21+ columns are included because they are the underage and legal age groups for alcohol.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.13A – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 48,722 48,464 2,228 2,192 46,494 46,272 9,669 9,228 36,825 37,044
GEOGRAPHIC REGION                    
Northeast 8,317 8,956 305 347 8,012 8,609 1,627 1,713 6,385 6,895
Midwest 10,503 10,106 463 476 10,039 9,630 2,113 2,001 7,926 7,629
South 17,046 17,702 895 848 16,151 16,854 3,357 3,276 12,793 13,578
West 12,857 11,699 565 520 12,291 11,179 2,571a 2,238 9,720 8,941
COUNTY TYPE                    
Large Metro 26,865 26,923 1,212 1,175 25,654 25,748 5,258 4,789 20,396 20,959
Small Metro 16,252 15,660 788 777 15,465 14,883 3,376 3,325 12,088 11,558
Nonmetro 5,604 5,881 229 240 5,376 5,641 1,035 1,114 4,341 4,526
Urbanized 2,457 2,459 108 84 2,349 2,375 476 542 1,873 1,834
Less Urbanized 2,715 3,012 85 128 2,630 2,884 521 511 2,110 2,374
Completely Rural 432 409 * 28 397 381 * 62 358 319
POVERTY LEVEL1                    
Less Than 100% 8,661 9,009 412 442 8,249 8,566 2,139 2,214 6,110 6,352
100-199% 10,192 9,307 629 489 9,562 8,818 2,526 2,238 7,036 6,581
200% or More 29,867 30,138 1,187 1,261 28,680 28,877 5,002 4,766 23,679 24,111
HEALTH INSURANCE2                    
Private 27,364 27,196 1,095 1,146 26,269 26,051 5,814 5,234 20,455 20,816
Medicaid/CHIP 12,773 12,821 1,044 1,001 11,729 11,819 2,438 2,675 9,291 9,144
Other3 9,325 9,405 154 122 9,172 9,283 748 780 8,423 8,503
No Coverage 5,163 5,267 84 72 5,079 5,195 1,124 1,091 3,955 4,104
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.13B – Substance Use Disorder in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 17.3 17.1 8.7 8.5 18.1 18.0 27.8 27.1 16.6 16.6
GEOGRAPHIC REGION                    
Northeast 17.0 18.3 7.5 8.5 17.8 19.2 27.5 29.8 16.4 17.6
Midwest 18.1 17.4 8.6 8.8 19.0 18.2 29.0 28.0 17.4 16.7
South 15.8 16.2 8.8 8.3 16.5 17.0 25.2 25.0 15.1 15.8
West 19.3a 17.5 9.2 8.5 20.3 18.4 31.2 27.9 18.6 16.9
COUNTY TYPE                    
Large Metro 17.2 17.2 8.2 8.2 18.2 18.1 27.5 26.1 16.7 16.9
Small Metro 18.2 17.6 9.9 9.4 19.0 18.4 28.9 29.1 17.4 16.7
Nonmetro 15.3 15.6 7.8 7.1 15.9 16.5 26.0 26.2 14.6 15.1
Urbanized 15.9 16.2 8.8 6.9 16.5 17.0 27.0 28.8 15.0 15.2
Less Urbanized 14.7 15.6 6.0 6.9 15.5 16.5 26.4 24.5 14.0 15.4
Completely Rural 15.1 13.2 * 9.2 15.4 13.6 * 21.2 15.4 12.7
POVERTY LEVEL1                    
Less Than 100% 20.9 19.9 7.8 7.7 22.8 21.7 26.6 26.3 21.7 20.5
100-199% 18.3 17.1 10.9 9.1 19.2 18.0 29.8 28.4 17.0 16.0
200% or More 16.2 16.4 8.1 8.5 16.8 17.1 27.4 26.9 15.6 15.9
HEALTH INSURANCE2                    
Private 16.1 15.9 7.8 8.2 16.8 16.6 29.3 27.4 15.0 15.1
Medicaid/CHIP 21.7 21.1 9.8 9.2 24.4 23.7 26.3 28.1 23.9 22.7
Other3 11.9 12.0 10.2 8.8 12.0 12.0 26.7 27.7 11.4 11.4
No Coverage 21.3 22.1 8.4 5.7 21.9 23.1 24.3 24.3 21.2 22.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
3 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.14A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2022 and 2023
Age Category Treatment for
Drugs
(2022)		 Treatment for
Drugs
(2023)		 Treatment for
Alcohol
(2022)		 Treatment for
Alcohol
(2023)		 Treatment for
Both Drugs
and Alcohol
(2022)		 Treatment for
Both Drugs
and Alcohol
(2023)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment for
Substance
Unspecified1
(2023)		 Treatment for
Substance Use1
(2022)		 Treatment for
Substance Use1
(2023)
TOTAL 6,185 6,073 4,338 4,519 1,669 1,736 4,251 3,931 13,106 12,786
12-202 986 915 333 330 134 121 559 542 1,744 1,665
21 or Older2 5,199 5,158 4,005 4,189 1,534 1,615 3,693 3,389 11,362 11,121
12-17 721 627 214 203 70 72 320 369 1,184 1,127
12-13 196 177 50 28 13 5 75 63 307 264
14-15 258 216 71 66 13 25 154 174 469 430
16-17 267 234 94 109 44 41 91 131 408 433
18 or Older 5,464 5,446 4,124 4,316 1,598 1,665 3,932 3,562 11,922 11,659
18-25 775 788 495 581 212 252 616 498 1,673 1,615
18-20 265 287 119 126 64 50 239 174 559 538
21-25 510 501 375 455 148 202 377 324 1,114 1,077
26 or Older 4,689 4,657 3,630 3,735 1,386 1,412 3,316 3,065 10,248 10,044
26-49 2,978 3,079 1,983 2,244 863 861 1,630 1,599 5,728 6,060
26-29 397 549 331 293 150 118 197 174 776 898
30-34 731 665 476 507 263 228 467 377 1,411 1,321
35-39 773 788 424 610 160 219 247 391 1,284 1,569
40-44 573 562 390 503 118 170 369 372 1,215 1,267
45-49 503 515 362 331 172 126 349 285 1,042 1,005
50 or Older 1,711 1,579 1,647 1,491 523 551 1,686 1,466 4,521 3,984
50-54 423 523 491 329 212 235 313 259 1,015 875
55-59 312 354 336 306 132 94 392 477 908 1,044
60-64 628a 265 285 489 127 103 411 235 1,197 886
65 or Older 348 437 536 367 52 119 569 495 1,401 1,179
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received.
2 The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.14B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2022 and 2023
Age Category Treatment for
Drugs
(2022)		 Treatment for
Drugs
(2023)		 Treatment for
Alcohol
(2022)		 Treatment for
Alcohol
(2023)		 Treatment for
Both Drugs
and Alcohol
(2022)		 Treatment for
Both Drugs
and Alcohol
(2023)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment for
Substance
Unspecified1
(2023)		 Treatment for
Substance Use1
(2022)		 Treatment for
Substance Use1
(2023)
TOTAL 2.2 2.1 1.5 1.6 0.6 0.6 1.5 1.4 4.6 4.5
12-202 2.6 2.4 0.9 0.9 0.3 0.3 1.4 1.4 4.5 4.4
21 or Older2 2.1 2.1 1.6 1.7 0.6 0.7 1.5 1.4 4.7 4.5
12-17 2.8 2.4 0.8 0.8 0.3 0.3 1.2 1.4 4.6 4.4
12-13 2.3 2.2 0.6 0.4 0.2 0.1 0.9 0.8 3.6 3.3
14-15 2.8 2.4 0.8 0.7 0.1 0.3 1.7 1.9 5.2 4.7
16-17 3.2 2.7 1.1 1.2 0.5 0.5 1.1 1.5 5.0 4.9
18 or Older 2.1 2.1 1.6 1.7 0.6 0.6 1.5 1.4 4.7 4.5
18-25 2.2 2.3 1.4 1.7 0.6 0.7 1.8 1.5 4.8 4.7
18-20 2.1 2.4 0.9 1.0 0.5 0.4 1.8 1.4 4.3 4.4
21-25 2.3 2.3 1.7 2.1 0.7 0.9 1.7 1.5 5.1 4.9
26 or Older 2.1 2.1 1.6 1.7 0.6 0.6 1.5 1.4 4.6 4.5
26-49 2.9 3.0 1.9 2.2 0.8 0.8 1.6 1.5 5.6 5.9
26-29 2.3 3.1 1.9 1.7 0.9 0.7 1.2 1.0 4.6 5.1
30-34 3.2 2.9 2.1 2.2 1.1 1.0 2.0 1.7 6.1 5.8
35-39 3.5 3.4 1.9 2.6 0.7 0.9 1.1 1.7 5.8 6.8
40-44 2.8 2.7 1.9 2.4 0.6 0.8 1.8 1.8 5.8 6.0
45-49 2.6 2.7 1.9 1.8 0.9 0.7 1.8 1.5 5.3 5.3
50 or Older 1.4 1.3 1.4 1.2 0.4 0.5 1.4 1.2 3.8 3.3
50-54 2.1 2.8 2.5 1.8 1.1 1.3 1.6 1.4 5.1 4.7
55-59 1.6 1.7 1.7 1.5 0.7 0.5 2.0 2.3 4.5 5.1
60-64 2.8a 1.2 1.3 2.1 0.6 0.5 1.8 1.0 5.3 3.9
65 or Older 0.6 0.8 0.9 0.6 0.1 0.2 1.0 0.9 2.5 2.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received.
2 The 12-20 and 21 or older rows are included because they are the underage and legal age groups for alcohol.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.15A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 13,106 12,786 1,184 1,127 11,922 11,659 1,673 1,615 10,248 10,044
SEX                    
Male 7,261 6,374 452 452 6,809 5,922 741 778 6,068a 5,144
Female 5,845 6,413 732 676 5,113 5,737 932 836 4,181a 4,901
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 10,992 10,477 845 838 10,146 9,639 1,334 1,219 8,812 8,420
AIAN 126 127 14 21 112 107 14 8 98 99
Asian 387 383 38 39 348 344 30 59 318 284
Black or African American 1,582 1,295 208a 131 1,375 1,164 203 193 1,172 971
NHOPI * * * * * * * * * *
White 8,416 8,226 543 582 7,874 7,644 1,050 921 6,824 6,723
Two or More Races 348 350 42 55 307 295 38 35 269 260
Hispanic or Latino 2,114 2,310 339 290 1,775 2,020 339 396 1,436 1,624
EDUCATION LEVEL                    
< High School da da da da 1,592 1,778 273 200 1,320 1,578
High School Graduate da da da da 4,128 3,962 595 600 3,533 3,362
Some College/Associate’s Degree da da da da 4,361a 3,615 686 638 3,675a 2,977
College Graduate da da da da 1,841a 2,304 120 177 1,720 2,127
EMPLOYMENT STATUS                    
Full-Time da da da da 4,220 4,617 595 621 3,624 3,996
Part-Time da da da da 1,748 1,620 415 446 1,332 1,174
Unemployed da da da da 935 930 174 151 760 778
Other1 da da da da 5,020 4,492 488 396 4,532 4,096
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.15B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 4.6 4.5 4.6 4.4 4.7 4.5 4.8 4.7 4.6 4.5
SEX                    
Male 5.3 4.6 3.4 3.4 5.4 4.7 4.2 4.6 5.6a 4.7
Female 4.1 4.4 5.8 5.3 3.9 4.3 5.4 4.9 3.7a 4.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 4.8 4.5 4.4 4.4 4.8 4.5 5.0 4.7 4.8 4.5
AIAN 8.6 9.5 6.5 8.8 9.0 9.7 6.4 5.5 9.5 10.3
Asian 2.3 2.2 2.4 2.7 2.3 2.1 1.3 2.7 2.4 2.1
Black or African American 4.6 3.7 5.9a 3.6 4.4 3.7 4.3 4.2 4.5 3.6
NHOPI * * * * * * * * * *
White 4.9 4.8 4.2 4.5 5.0 4.9 5.8 5.2 4.9 4.8
Two or More Races 5.9 5.7 5.0 5.9 6.1 5.6 3.8 3.2 6.6 6.2
Hispanic or Latino 4.2 4.4 5.1 4.3 4.0 4.4 4.1 4.8 4.0 4.4
EDUCATION LEVEL                    
< High School da da da da 6.5 7.3 7.6 5.6 6.4 7.5
High School Graduate da da da da 6.0 5.7 5.1 5.2 6.1 5.8
Some College/Associate’s Degree da da da da 5.6a 4.7 4.9 4.8 5.8a 4.7
College Graduate da da da da 2.2 2.7 2.1 3.1 2.2 2.6
EMPLOYMENT STATUS                    
Full-Time da da da da 3.6 3.8 4.2 4.5 3.5 3.7
Part-Time da da da da 5.3 5.1 4.7 5.3 5.5 5.1
Unemployed da da da da 8.5 8.1 5.4 4.5 9.7 9.6
Other1 da da da da 5.3 4.8 5.6 4.7 5.3 4.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.16A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Treatment for
Drugs
(2022)		 Treatment for
Drugs
(2023)		 Treatment for
Alcohol
(2022)		 Treatment for
Alcohol
(2023)		 Treatment for
Both Drugs
and Alcohol
(2022)		 Treatment for
Both Drugs
and Alcohol
(2023)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment for
Substance
Unspecified1
(2023)		 Treatment for
Substance
Use1
(2022)		 Treatment for
Substance
Use1
(2023)
TOTAL 6,185 6,073 4,338 4,519 1,669 1,736 4,251 3,931 13,106 12,786
SEX                    
Male 3,375 2,939 2,674 2,549 1,024 1,017 2,236 1,903 7,261 6,374
Female 2,810 3,134 1,664 1,970 645 719 2,016 2,028 5,845 6,413
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 5,050 5,103 3,534 3,609 1,353 1,345 3,761a 3,110 10,992 10,477
AIAN 94 75 64 61 38 44 6 35 126 127
Asian 63a 168 133 142 24 21 215 94 387 383
Black or African American 745 592 507 351 232 147 562 499 1,582 1,295
NHOPI * 30 * * * * * * * *
White 3,965 4,121 2,735 2,909 1,011 1,073 2,727 2,268 8,416 8,226
Two or More Races 151 117 60 129 17 46 155 149 348 350
Hispanic or Latino 1,135 969 804 910 316 391 491b 821 2,114 2,310
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.16B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Treatment for
Drugs
(2022)		 Treatment for
Drugs
(2023)		 Treatment for
Alcohol
(2022)		 Treatment for
Alcohol
(2023)		 Treatment for
Both Drugs
and Alcohol
(2022)		 Treatment for
Both Drugs
and Alcohol
(2023)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment for
Substance
Unspecified1
(2023)		 Treatment for
Substance
Use1
(2022)		 Treatment for
Substance
Use1
(2023)
TOTAL 2.2 2.1 1.5 1.6 0.6 0.6 1.5 1.4 4.6 4.5
SEX                    
Male 2.4 2.1 1.9 1.8 0.7 0.7 1.6 1.4 5.3 4.6
Female 2.0 2.2 1.2 1.4 0.4 0.5 1.4 1.4 4.1 4.4
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 2.2 2.2 1.5 1.6 0.6 0.6 1.6a 1.3 4.8 4.5
AIAN 6.4 5.6 4.4 4.6 2.6 3.3 0.4 2.6 8.6 9.5
Asian 0.4a 1.0 0.8 0.8 0.1 0.1 1.3 0.5 2.3 2.2
Black or African American 2.2 1.7 1.5 1.0 0.7 0.4 1.6 1.4 4.6 3.7
NHOPI * 2.7 * * * * * * * *
White 2.3 2.4 1.6 1.7 0.6 0.6 1.6 1.3 4.9 4.8
Two or More Races 2.6 1.9 1.0 2.1 0.3 0.7 2.6 2.4 5.9 5.7
Hispanic or Latino 2.2 1.9 1.6 1.7 0.6 0.7 1.0a 1.6 4.2 4.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.17A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older with Past Year Substance Use Disorder; by Age Group and Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 7,253 7,064 453 423 6,800 6,641 1,164 1,087 5,636 5,555
SEX                    
Male 4,046 3,769 153 143 3,893 3,626 508 574 3,385 3,053
Female 3,207 3,295 300 280 2,906 3,015 656 513 2,250 2,502
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 6,144 5,697 335 314 5,809 5,383 927 818 4,882 4,565
AIAN * * * * * * * * * *
Asian * 151 * * * 128 12 * * 91
Black or African American 883b 564 55 33 828a 530 132 133 696b 397
NHOPI * * * * * * * * * *
White 4,689 4,643 234 235 4,455 4,407 749 613 3,706 3,794
Two or More Races 213 230 * * 191 215 24 29 168 186
Hispanic or Latino 1,108 1,366 118 108 991 1,258 237 269 754 989
EDUCATION LEVEL                    
< High School da da da da 908 949 173 138 736 811
High School Graduate da da da da 2,309 2,127 380 385 1,929 1,743
Some College/Associate’s Degree da da da da 2,594 2,304 513 443 2,080 1,861
College Graduate da da da da 989 1,260 98 121 891 1,140
EMPLOYMENT STATUS                    
Full-Time da da da da 2,516 2,482 440 434 2,076 2,049
Part-Time da da da da 1,069 1,012 316 298 753 714
Unemployed da da da da 607 636 140 110 467 527
Other1 da da da da 2,607 2,510 267 245 2,340 2,265
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.17B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older with Past Year Substance Use Disorder; by Age Group and Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
TOTAL 14.9 14.6 20.3 19.3 14.6 14.4 12.0 11.8 15.3 15.0
SEX                    
Male 14.6 13.6 15.6 16.7 14.6 13.5 10.1 11.8 15.7 13.9
Female 15.2 15.9 24.0 20.9 14.7 15.6 14.2 11.7 14.8 16.7
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 15.4 14.1 21.5 20.7 15.2 13.9 12.5 11.5 15.8 14.4
AIAN * * * * * * * * * *
Asian * 9.4 * * * 8.3 4.1 * * 7.7
Black or African American 14.0a 9.2 17.6 12.6 13.8a 9.1 11.9 10.5 14.2a 8.7
NHOPI * * * * * * * * * *
White 15.6 15.3 21.7 21.9 15.4 15.0 13.4 12.2 15.8 15.6
Two or More Races 16.7 15.3 * * 16.0 15.3 7.8 7.9 18.7 17.9
Hispanic or Latino 12.5 16.7 17.6 16.1 12.1a 16.7 10.5 12.8 12.7 18.2
EDUCATION LEVEL                    
< High School da da da da 21.0 20.9 18.1 14.3 21.8 22.8
High School Graduate da da da da 18.3 16.1 12.4 12.3 20.1 17.3
Some College/Associate’s Degree da da da da 16.3 15.4 13.0 11.9 17.5 16.6
College Graduate da da da da 7.2 9.3 5.8 8.6 7.4 9.4
EMPLOYMENT STATUS                    
Full-Time da da da da 10.6 10.4 9.8 10.5 10.7 10.4
Part-Time da da da da 15.9 16.3 13.1 12.5 17.4 18.7
Unemployed da da da da 19.8 19.3 15.4 10.8 21.6 23.0
Other1 da da da da 20.3 19.5 14.3 14.5 21.3 20.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.18A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic Treatment
for Drugs
(2022)		 Treatment
for Drugs
(2023)		 Treatment
for Alcohol
(2022)		 Treatment
for Alcohol
(2023)		 Treatment
for Both
Drugs and
Alcohol
(2022)		 Treatment
for Both
Drugs and
Alcohol
(2023)		 Treatment
for Substance
Unspecified1
(2022)		 Treatment
for Substance
Unspecified1
(2023)		 Treatment
for Substance
Use1
(2022)		 Treatment
for Substance
Use1
(2023)
TOTAL 6,185 6,073 4,338 4,519 1,669 1,736 4,251 3,931 13,106 12,786
GEOGRAPHIC REGION                    
Northeast 1,145 1,252 940 1,001 312 286 867 636 2,640 2,602
Midwest 1,351 1,195 912 924 322 382 1,016 785 2,957 2,522
South 2,255 2,227 1,481 1,489 602 576 1,521 1,581 4,655 4,720
West 1,434 1,399 1,005 1,105 433 492 848 929 2,853 2,942
COUNTY TYPE                    
Large Metro 3,022 2,892 2,187 2,396 828 908 1,966 2,133 6,347 6,513
Small Metro 2,190 2,078 1,449 1,593 609 587 1,555 1,235 4,585 4,320
Nonmetro 973 1,103 702 529 231 241 730 563 2,173 1,954
Urbanized 373 500 223 229 47a 111 356 193 904 810
Less Urbanized 506 532 457 232 172 93 264 338 1,055 1,011
Completely Rural 93 71 22 68 11 37 110 32 214 133
POVERTY LEVEL2                    
Less Than 100% 1,844 2,053 1,075 1,083 464 574 1,155 1,051 3,610 3,613
100-199% 1,881a 1,360 1,174a 780 560 353 1,097 945 3,591b 2,733
200% or More 2,460 2,656 2,090a 2,655 644 809 1,999 1,935 5,905 6,437
HEALTH INSURANCE3                    
Private 2,223 2,214 1,849 2,041 643 497 1,907 1,846 5,337 5,604
Medicaid/CHIP 3,225 3,049 1,655 1,808 877 933 1,636 1,396 5,639 5,320
Other4 1,509 1,265 1,349 1,051 441 367 1,540 1,054 3,957a 3,004
No Coverage 500 525 523 361 177 170 256 352 1,102 1,068
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.18B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic Treatment
for Drugs
(2022)		 Treatment
for Drugs
(2023)		 Treatment
for Alcohol
(2022)		 Treatment
for Alcohol
(2023)		 Treatment
for Both
Drugs and
Alcohol
(2022)		 Treatment
for Both
Drugs and
Alcohol
(2023)		 Treatment
for Substance
Unspecified1
(2022)		 Treatment
for Substance
Unspecified1
(2023)		 Treatment
for Substance
Use1
(2022)		 Treatment
for Substance
Use1
(2023)
TOTAL 2.2 2.1 1.5 1.6 0.6 0.6 1.5 1.4 4.6 4.5
GEOGRAPHIC REGION                    
Northeast 2.3 2.6 1.9 2.0 0.6 0.6 1.8 1.3 5.4 5.3
Midwest 2.3 2.1 1.6 1.6 0.6 0.7 1.7 1.3 5.1 4.3
South 2.1 2.0 1.4 1.4 0.6 0.5 1.4 1.4 4.3 4.3
West 2.1 2.1 1.5 1.6 0.6 0.7 1.3 1.4 4.3 4.4
COUNTY TYPE                    
Large Metro 1.9 1.8 1.4 1.5 0.5 0.6 1.3 1.4 4.1 4.2
Small Metro 2.5 2.3 1.6 1.8 0.7 0.7 1.7 1.4 5.1 4.9
Nonmetro 2.6 2.9 1.9 1.4 0.6 0.6 2.0 1.5 5.9 5.2
Urbanized 2.4 3.3 1.4 1.5 0.3a 0.7 2.3 1.3 5.8 5.3
Less Urbanized 2.7 2.8 2.5a 1.2 0.9 0.5 1.4 1.7 5.7 5.2
Completely Rural 3.3 2.3 0.8 2.2 0.4 1.2 3.8 1.0 7.5 4.3
POVERTY LEVEL2                    
Less Than 100% 4.4 4.5 2.6 2.4 1.1 1.3 2.8 2.3 8.7 8.0
100-199% 3.4a 2.5 2.1a 1.4 1.0 0.6 2.0 1.7 6.5b 5.0
200% or More 1.3 1.4 1.1a 1.4 0.3 0.4 1.1 1.1 3.2 3.5
HEALTH INSURANCE3                    
Private 1.3 1.3 1.1 1.2 0.4 0.3 1.1 1.1 3.1 3.3
Medicaid/CHIP 5.5 5.0 2.8 3.0 1.5 1.5 2.8 2.3 9.6 8.8
Other4 1.9 1.6 1.7 1.3 0.6 0.5 2.0a 1.3 5.1a 3.8
No Coverage 2.1 2.2 2.2 1.5 0.7 0.7 1.1 1.5 4.5 4.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.19A – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; by Age Group, Numbers in Thousands, 2022 and 2023
Substance for Which Treatment Was Received1 Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE TREATMENT2 3,488 3,538 331 366 3,158 3,172 494 496 2,664 2,677
DRUGS 1,507 1,504 192 177 1,314 1,327 226 245 1,089 1,082
Marijuana 429 479 75 52 354 427 98 102 256 325
Cocaine 309 298 2 * 308 287 26 38 282 249
Heroin 341 372 <1 7 340 365 22 14 319 351
Hallucinogens 105 185 30 25 75 160 35 52 40 108
Inhalants 83 105 17 15 66 90 15 * 51 77
Methamphetamine 476 479 3 1 474 478 55 33 419 445
Prescription Psychotherapeutics 638 577 123 105 516 472 117 118 399 354
Pain Relievers 467 422 73 74 394 347 75 88 318 259
Stimulants 194 132 39 22 155 110 * 13 112 97
Tranquilizers or Sedatives 205 223 37 19 168 204 21 30 147 174
Tranquilizers 150 164 13 12 137 152 17 22 119 130
Sedatives 120 149 * 12 94 137 11 11 83 126
Opioids 712 709 73 77 639 631 87 100 552 531
Central Nervous System Stimulants 810 754 42 35 769 719 91 71 678 648
ALCOHOL 1,267 1,379 59 70 1,208 1,310 167 186 1,041 1,123
BOTH DRUGS AND ALCOHOL 367 473 17 29 350 444 67 72 283 372
SUBSTANCE UNSPECIFIED2 1,083 1,128 97 149 985 980 169 136 816 844
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.
2 Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.19B – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Inpatient in Past Year; by Age Group, Percentages, 2022 and 2023
Substance for Which Treatment Was Received1 Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE TREATMENT2 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
DRUGS 43.2 42.5 58.1 48.4 41.6 41.8 45.7 49.5 40.9 40.4
Marijuana 12.3 13.6 22.7 14.2 11.2 13.5 19.7 20.6 9.6 12.2
Cocaine 8.9 8.4 0.5 * 9.7 9.0 5.2 7.7 10.6 9.3
Heroin 9.8 10.5 0.1 1.8 10.8 11.5 4.4 2.8 12.0 13.1
Hallucinogens 3.0 5.2 9.2 6.8 2.4 5.0 7.1 10.6 1.5 4.0
Inhalants 2.4 3.0 5.2 4.0 2.1 2.9 3.0 * 1.9 2.9
Methamphetamine 13.7 13.5 0.8 0.3 15.0 15.1 11.1 6.6 15.7 16.6
Prescription Psychotherapeutics 18.3 16.3 37.1 28.6 16.3 14.9 23.7 23.8 15.0 13.2
Pain Relievers 13.4 11.9 22.1 20.3 12.5 10.9 15.2 17.8 12.0 9.7
Stimulants 5.6 3.7 11.8 6.1 4.9 3.5 * 2.6 4.2 3.6
Tranquilizers or Sedatives 5.9 6.3 11.3 5.2 5.3 6.4 4.3 6.1 5.5 6.5
Tranquilizers 4.3 4.6 4.0 3.2 4.3 4.8 3.5 4.4 4.5 4.9
Sedatives 3.4 4.2 * 3.2 3.0 4.3 2.2 2.3 3.1 4.7
Opioids 20.4 20.0 22.1 21.2 20.2 19.9 17.5 20.2 20.7 19.8
Central Nervous System Stimulants 23.2 21.3 12.6 9.6 24.3 22.7 18.4 14.3 25.4 24.2
ALCOHOL 36.3 39.0 17.7 19.0 38.3 41.3 33.8 37.6 39.1 42.0
BOTH DRUGS AND ALCOHOL 10.5 13.4 5.2 8.0 11.1 14.0 13.6 14.5 10.6 13.9
SUBSTANCE UNSPECIFIED2 31.0 31.9 29.4 40.6 31.2 30.9 34.2 27.4 30.7 31.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.
2 Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.20A – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; by Age Group, Numbers in Thousands, 2022 and 2023
Substance for Which Treatment Was Received1 Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE TREATMENT2 9,910 9,816 952 865 8,958 8,951 1,203 1,202 7,755 7,749
DRUGS 3,806 4,024 523 452 3,283 3,572 474 514 2,809 3,058
Marijuana 905 1,165 199 151 705a 1,015 231 276 474 739
Cocaine 535 542 4 22 531 520 44 40 488 480
Heroin 789 832 <1 * 789 828 36 19 752 810
Hallucinogens 156 200 35a 6 121 194 29 49 92 145
Inhalants 98 199 54 64 44 136 33 13 11a 123
Methamphetamine 708 847 6 10 702 836 54 38 648 799
Prescription Psychotherapeutics 2,158 2,176 337 244 1,821 1,932 217 251 1,604 1,681
Pain Relievers 1,571 1,601 225 163 1,346 1,439 102 118 1,244 1,320
Stimulants 476 597 103a 59 373 538 104 106 269 432
Tranquilizers or Sedatives 540 544 55 35 486 509 51 50 434 459
Tranquilizers 455 464 32 27 423 437 39 35 384 402
Sedatives 236 255 32 12 204 244 29 17 175 227
Opioids 2,058 2,035 225 163 1,833 1,872 115 128 1,717 1,744
Central Nervous System Stimulants 1,467 1,635 112 81 1,354 1,554 163 171 1,191 1,383
ALCOHOL 2,520 2,669 136 130 2,384 2,539 247 340 2,136 2,200
BOTH DRUGS AND ALCOHOL 736 790 38 41 698 749 98 123 600 626
SUBSTANCE UNSPECIFIED2 4,320 3,914 331 324 3,989 3,589 580 472 3,409 3,117
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.
2 Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.20B – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older Who Received Substance Use Treatment as an Outpatient in Past Year; by Age Group, Percentages, 2022 and 2023
Substance for Which Treatment Was Received1 Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE TREATMENT2 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
DRUGS 38.4 41.0 54.9 52.3 36.7 39.9 39.4 42.7 36.2 39.5
Marijuana 9.1 11.9 20.9 17.4 7.9a 11.3 19.2 23.0 6.1a 9.5
Cocaine 5.4 5.5 0.4 2.5 5.9 5.8 3.6 3.4 6.3 6.2
Heroin 8.0 8.5 <0.1 * 8.8 9.3 3.0 1.5 9.7 10.4
Hallucinogens 1.6 2.0 3.7a 0.7 1.4 2.2 2.4 4.1 1.2 1.9
Inhalants 1.0 2.0 5.7 7.4 0.5 1.5 2.7 1.1 0.1a 1.6
Methamphetamine 7.1 8.6 0.6 1.2 7.8 9.3 4.5 3.1 8.4 10.3
Prescription Psychotherapeutics 21.8 22.2 35.4 28.2 20.3 21.6 18.0 20.9 20.7 21.7
Pain Relievers 15.9 16.3 23.6 18.8 15.0 16.1 8.4 9.8 16.0 17.0
Stimulants 4.8 6.1 10.8 6.8 4.2 6.0 8.7 8.9 3.5 5.6
Tranquilizers or Sedatives 5.5 5.5 5.7 4.1 5.4 5.7 4.3 4.2 5.6 5.9
Tranquilizers 4.6 4.7 3.3 3.1 4.7 4.9 3.2 3.0 5.0 5.2
Sedatives 2.4 2.6 3.4 1.4 2.3 2.7 2.4 1.4 2.3 2.9
Opioids 20.8 20.7 23.6 18.8 20.5 20.9 9.6 10.6 22.1 22.5
Central Nervous System Stimulants 14.8 16.7 11.8 9.4 15.1 17.4 13.6 14.2 15.4 17.8
ALCOHOL 25.4 27.2 14.3 15.0 26.6 28.4 20.6 28.3 27.6 28.4
BOTH DRUGS AND ALCOHOL 7.4 8.1 4.0 4.8 7.8 8.4 8.1 10.3 7.7 8.1
SUBSTANCE UNSPECIFIED2 43.6 39.9 34.8 37.5 44.5 40.1 48.2a 39.3 44.0 40.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Respondents could indicate multiple substances for which they received substance use treatment; thus, these response categories are not mutually exclusive.
2 Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.21A – Received Medication-Assisted Treatment (MAT) for Alcohol Use in Past Year: Among People Aged 12 or Older; Received MAT for Alcohol Use in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Received MAT for
Alcohol Use
(2022)		 Received MAT for
Alcohol Use
(2023)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2022)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2023)
TOTAL 1,243 1,146 634 554
AGE GROUP        
12-17 44a 13 10 2
18 or Older 1,199 1,133 624 552
18-25 95 88 26 58
26 or Older 1,104 1,044 598 494
SEX        
Male 889a 553 500a 253
Female 354a 593 134b 301
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 1,035 996 547 497
AIAN 17 * 5 <1
Asian 27 9 * *
Black or African American 151 94 95 29
NHOPI * <1 * *
White 802 866 416 452
Two or More Races 12 13 6 9
Hispanic or Latino 208 150 86 57
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for alcohol use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Alcohol use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.21B – Received Medication-Assisted Treatment (MAT) for Alcohol Use in Past Year: Among People Aged 12 or Older; Received MAT for Alcohol Use in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Received MAT for
Alcohol Use
(2022)		 Received MAT for
Alcohol Use
(2023)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2022)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2023)
TOTAL 0.4 0.4 2.1 1.9
AGE GROUP        
12-17 0.2a 0.1 1.3 0.3
18 or Older 0.5 0.4 2.2 2.0
18-25 0.3 0.3 0.4a 1.1
26 or Older 0.5 0.5 2.6 2.2
SEX        
Male 0.6a 0.4 2.9a 1.5
Female 0.2a 0.4 1.1b 2.5
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 0.4 0.4 2.3 2.1
AIAN 1.1 * 2.9 <0.1
Asian 0.2 <0.1 * *
Black or African American 0.4 0.3 2.6 0.9
NHOPI * <0.1 * *
White 0.5 0.5 2.2 2.4
Two or More Races 0.2 0.2 0.9 1.1
Hispanic or Latino 0.4 0.3 1.6 1.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for alcohol use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Alcohol use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.22A – Received Medication-Assisted Treatment (MAT) for Opioid Use in Past Year: Among People Aged 12 or Older; Received MAT for Opioid Use in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Received MAT for
Opioid Use
(2022)		 Received MAT for
Opioid Use
(2023)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2022)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2023)
TOTAL 2,392 2,296 1,121 1,025
AGE GROUP        
12-17 40 37 20 *
18 or Older 2,353 2,258 1,102 1,007
18-25 90 99 44 44
26 or Older 2,262 2,159 1,058 963
SEX        
Male 1,395 1,142 698 549
Female 997 1,153 424 476
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 2,067 1,977 951 872
AIAN 17 16 * *
Asian 6 14 * *
Black or African American 213 136 117 *
NHOPI * 2 * *
White 1,748 1,781 758 762
Two or More Races 57 29 * *
Hispanic or Latino 325 319 171 *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for opioid use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of opioids.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Opioid use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.22B – Received Medication-Assisted Treatment (MAT) for Opioid Use in Past Year: Among People Aged 12 or Older; Received MAT for Opioid Use in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Received MAT for
Opioid Use
(2022)		 Received MAT for
Opioid Use
(2023)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2022)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2023)
TOTAL 0.8 0.8 18.3 18.0
AGE GROUP        
12-17 0.2 0.1 7.5 *
18 or Older 0.9 0.9 18.8 18.8
18-25 0.3 0.3 10.3 11.1
26 or Older 1.0 1.0 19.5 19.4
SEX        
Male 1.0 0.8 22.9 20.3
Female 0.7 0.8 13.8 16.0
HISPANIC ORIGIN AND RACE        
Not Hispanic or Latino 0.9 0.9 18.7 18.5
AIAN 1.2 1.2 * *
Asian <0.1 0.1 * *
Black or African American 0.6 0.4 11.2 *
NHOPI * 0.1 * *
White 1.0 1.0 21.7 22.7
Two or More Races 1.0 0.5 * *
Hispanic or Latino 0.6 0.6 16.4 *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for opioid use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of opioids.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Opioid use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.23A – Received Medication-Assisted Treatment (MAT) for Alcohol Use in Past Year: Among People Aged 12 or Older; Received MAT for Alcohol Use in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic Received MAT for
Alcohol Use
(2022)		 Received MAT for
Alcohol Use
(2023)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2022)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2023)
TOTAL 1,243 1,146 634 554
GEOGRAPHIC REGION        
Northeast 300 197 158 81
Midwest 261 247 144 149
South 348 488 134 159
West 334 214 198 165
COUNTY TYPE        
Large Metro 745 596 325 231
Small Metro 324 409 194 245
Nonmetro 174 141 114 78
Urbanized 44 46 13 15
Less Urbanized 127 84 * 53
Completely Rural 3 11 * *
POVERTY LEVEL2        
Less Than 100% 283 254 174 151
100-199% 403a 159 156 74
200% or More 556 733 303 330
HEALTH INSURANCE3        
Private 561 493 309 172
Medicaid/CHIP 555 492 262 300
Other4 461 251 216 93
No Coverage 106 79 57 41
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for alcohol use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Alcohol use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.23B – Received Medication-Assisted Treatment (MAT) for Alcohol Use in Past Year: Among People Aged 12 or Older; Received MAT for Alcohol Use in Past Year: Among People Aged 12 or Older with Past Year Alcohol Use Disorder; by Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic Received MAT for
Alcohol Use
(2022)		 Received MAT for
Alcohol Use
(2023)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2022)		 Received MAT for
Alcohol Use among
People with an Alcohol
Use Disorder1
(2023)
TOTAL 0.4 0.4 2.1 1.9
GEOGRAPHIC REGION        
Northeast 0.6 0.4 3.1 1.6
Midwest 0.4 0.4 2.3 2.4
South 0.3 0.4 1.3 1.5
West 0.5 0.3 2.5 2.4
COUNTY TYPE        
Large Metro 0.5 0.4 1.9 1.4
Small Metro 0.4 0.5 2.0 2.6
Nonmetro 0.5 0.4 3.5 2.6
Urbanized 0.3 0.3 0.9 1.2
Less Urbanized 0.7 0.4 * 3.4
Completely Rural 0.1 0.3 * *
POVERTY LEVEL2        
Less Than 100% 0.7 0.6 4.0 3.5
100-199% 0.7a 0.3 3.0 1.5
200% or More 0.3 0.4 1.5 1.7
HEALTH INSURANCE3        
Private 0.3 0.3 1.7 1.0
Medicaid/CHIP 0.9 0.8 4.6 5.1
Other4 0.6 0.3 4.2 1.8
No Coverage 0.4 0.3 1.8 1.3
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for alcohol use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of alcohol.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Alcohol use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on alcohol use disorder.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.24A – Received Medication-Assisted Treatment (MAT) for Opioid Use in Past Year: Among People Aged 12 or Older; Received MAT for Opioid Use in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic Received MAT for
Opioid Use
(2022)		 Received MAT for
Opioid Use
(2023)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2022)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2023)
TOTAL 2,392 2,296 1,121 1,025
GEOGRAPHIC REGION        
Northeast 523 513 297 191
Midwest 483 494 249 182
South 1,052 784 427 361
West 335 505 148 *
COUNTY TYPE        
Large Metro 1,286 993 651 571
Small Metro 737 796 343 256
Nonmetro 369 508 128 *
Urbanized 144 220 57 *
Less Urbanized 163 268 * *
Completely Rural 63 20 * *
POVERTY LEVEL2        
Less Than 100% 690 796 384 382
100-199% 726 519 360 258
200% or More 976 980 378 385
HEALTH INSURANCE3        
Private 765 788 300 333
Medicaid/CHIP 1,438 1,225 786a 532
Other4 540 476 250 236
No Coverage 183 172 * *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for opioid use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of opioids.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Opioid use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.24B – Received Medication-Assisted Treatment (MAT) for Opioid Use in Past Year: Among People Aged 12 or Older; Received MAT for Opioid Use in Past Year: Among People Aged 12 or Older with Past Year Opioid Use Disorder; by Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic Received MAT for
Opioid Use
(2022)		 Received MAT for
Opioid Use
(2023)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2022)		 Received MAT for
Opioid Use among
People with an Opioid
Use Disorder1
(2023)
TOTAL 0.8 0.8 18.3 18.0
GEOGRAPHIC REGION        
Northeast 1.1 1.0 29.0 21.2
Midwest 0.8 0.8 18.3 18.0
South 1.0 0.7 17.2 14.9
West 0.5 0.8 11.9 *
COUNTY TYPE        
Large Metro 0.8 0.6 20.3 20.0
Small Metro 0.8 0.9 17.4 13.9
Nonmetro 1.0 1.3 13.6 *
Urbanized 0.9 1.4 15.1 *
Less Urbanized 0.9 1.4 * *
Completely Rural 2.2 0.7 * *
POVERTY LEVEL2        
Less Than 100% 1.7 1.8 21.6 21.9
100-199% 1.3 1.0 22.7 21.0
200% or More 0.5 0.5 13.7 14.2
HEALTH INSURANCE3        
Private 0.4 0.5 13.1 14.1
Medicaid/CHIP 2.4 2.0 28.1 24.1
Other4 0.7 0.6 10.7 10.2
No Coverage 0.8 0.7 * *
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Medication-assisted treatment for opioid use refers to medication prescribed by a doctor or other health professional to help reduce or stop the use of opioids.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Opioid use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on opioid use disorder.
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.25A – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder
(2022)		 Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder
(2023)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2022)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2023)		 Received Telehealth
Treatment for
Substance Use among
People with a Substance
Use Disorder1
(2022)		 Received Telehealth
Treatment for
Substance Use among
People with a Substance
Use Disorder1
(2023)
TOTAL 1,444 1,650 1,084 1,241 2,605 3,007
AGE GROUP            
12-17 131 85 29 22 143 102
18 or Older 1,313 1,566 1,055 1,219 2,461 2,905
18-25 199 238 149 188 354 409
26 or Older 1,114 1,327 906 1,031 2,108 2,495
SEX            
Male 769 821 646 760 1,393 1,590
Female 675 829 438 481 1,212 1,416
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 1,193 1,322 949 1,010 2,265 2,457
AIAN 15 15 6 2 19 16
Asian 8 26 * 28 32 49
Black or African American 106 148 126 76 274 240
NHOPI * * * * * *
White 1,016 1,090 788 829 1,819 2,043
Two or More Races 47 29 6a 74 74 93
Hispanic or Latino 251 328 135 232 340 549
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s).
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.25B – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder
(2022)		 Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder
(2023)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2022)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2023)		 Received Telehealth
Treatment for
Substance Use among
People with a Substance
Use Disorder1
(2022)		 Received Telehealth
Treatment for
Substance Use among
People with a Substance
Use Disorder1
(2023)
TOTAL 5.3 6.1 3.7 4.3 5.3 6.2
AGE GROUP            
12-17 7.2 4.8 3.8 3.0 6.4 4.7
18 or Older 5.2 6.2 3.7 4.3 5.3 6.3
18-25 3.1 3.9 2.6 3.7 3.7 4.4
26 or Older 5.9 6.9 3.9 4.5 5.7 6.7
SEX            
Male 5.1 5.4 3.7 4.5 5.0 5.7
Female 5.6 7.1 3.6 4.0 5.8 6.8
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 5.4 5.9 4.0 4.2 5.7 6.1
AIAN 5.9 5.8 3.9 1.2 5.5 4.7
Asian 1.0 3.4 * 2.8 2.1 3.1
Black or African American 2.7 3.8 3.5 2.3 4.3 3.9
NHOPI * * * * * *
White 6.4 6.7 4.3 4.5 6.1 6.7
Two or More Races 5.2 3.1 1.0a 8.8 5.8 6.2
Hispanic or Latino 5.0 7.2 2.5 4.8 3.8a 6.7
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s).
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.26A – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2022 and 2023
Geographic/Socioeconomic Characteristic Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder
(2022)		 Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder
(2023)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2022)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2023)		 Received Telehealth
Treatment for
Substance Use among
People with a Substance
Use Disorder1
(2022)		 Received Telehealth
Treatment for
Substance Use among
People with a Substance
Use Disorder1
(2023)
TOTAL 1,444 1,650 1,084 1,241 2,605 3,007
GEOGRAPHIC REGION            
Northeast 341 372 167 266 581 714
Midwest 370 304 237 235 578 536
South 489 497 293 385 779 937
West 244a 478 388 355 667 819
COUNTY TYPE            
Large Metro 761 1,033 520 656 1,286a 1,694
Small Metro 506 395 327 459 845 929
Nonmetro 177 222 237 126 474 384
Urbanized 66 80 56 35 206 135
Less Urbanized 103 141 * 50 260 207
Completely Rural * * * * * *
POVERTY LEVEL2            
Less Than 100% 416 520 238 257 683 784
100-199% 417 390 299a 125 715 593
200% or More 611 737 547a 858 1,206a 1,627
HEALTH INSURANCE3            
Private 502 552 529 575 1,001 1,175
Medicaid/CHIP 929 975 475 451 1,424 1,495
Other4 269 301 377 261 610 649
No Coverage 76 87 46 64 140 161
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s).
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.26B – Received Substance Use Treatment through Telehealth: Among People Aged 12 or Older with Drug Use Disorder, Alcohol Use Disorder, and Substance Use Disorder in Past Year; by Geographic and Socioeconomic Characteristics, Percentages, 2022 and 2023
Geographic/Socioeconomic Characteristic Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder
(2022)		 Received Telehealth
Treatment for Drug Use
among People with a
Drug Use Disorder
(2023)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2022)		 Received Telehealth
Treatment for Alcohol
Use among People with
an Alcohol Use Disorder
(2023)		 Received Telehealth
Treatment for
Substance Use among
People with a Substance
Use Disorder1
(2022)		 Received Telehealth
Treatment for
Substance Use among
People with a Substance
Use Disorder1
(2023)
TOTAL 5.3 6.1 3.7 4.3 5.3 6.2
GEOGRAPHIC REGION            
Northeast 7.9 7.3 3.2 5.2 7.0 8.0
Midwest 6.5 5.4 3.7 3.9 5.5 5.3
South 5.1 5.3 2.9 3.6 4.6 5.3
West 3.2b 6.9 4.9 5.3 5.2 7.0
COUNTY TYPE            
Large Metro 5.2 7.1 3.1 4.0 4.8a 6.3
Small Metro 5.5 4.5 3.4 4.9 5.2 5.9
Nonmetro 5.4 6.1 7.3 4.2 8.5 6.5
Urbanized 4.6 5.2 3.9 2.7 8.4 5.5
Less Urbanized 6.7 7.5 * 3.3 9.6 6.9
Completely Rural * * * * * *
POVERTY LEVEL2            
Less Than 100% 7.1 8.4 5.5 6.0 7.9 8.7
100-199% 6.2 6.3 5.7 2.6 7.0 6.4
200% or More 4.2 5.1 2.8b 4.3 4.0a 5.4
HEALTH INSURANCE3            
Private 3.9 4.2 2.9 3.2 3.7 4.3
Medicaid/CHIP 9.8 10.6 8.3 7.8 11.2 11.7
Other4 5.0 5.6 7.3 5.0 6.5 6.9
No Coverage 2.5 2.7 1.4 2.1 2.7 3.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Includes people who received treatment specifically for drugs or alcohol, as well as people who received treatment for unspecified substance(s).
2 Respondents aged 18 to 22 who were living in a college dormitory were excluded.
3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive.
4 Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.27A – Types and Locations of Substance Use Treatment and Other Services in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2022 and 2023
Type/Location of Treatment or Other Services Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE TREATMENT OR OTHER SERVICES1,2 16,093 15,796 1,287 1,248 14,806 14,548 1,963 1,882 12,842 12,665
SUBSTANCE USE TREATMENT1 13,106 12,786 1,184 1,127 11,922 11,659 1,673 1,615 10,248 10,044
Inpatient1 3,488 3,538 331 366 3,158 3,172 494 496 2,664 2,677
Hospital1 2,212 2,117 178 182 2,034 1,935 336 304 1,698 1,631
Residential Drug or Alcohol Rehab or Treatment Center1 1,600 1,796 73 60 1,526 1,736 141 186 1,386 1,550
Residential Mental Health Treatment Center1 1,387 1,395 181 203 1,206 1,193 242 242 964 951
Some Other Place as an Inpatient1 925 832 99 117 827 715 146 142 680 573
Outpatient1 9,910 9,816 952 865 8,958 8,951 1,203 1,202 7,755 7,749
Drug or Alcohol Rehab or Treatment Center1 2,247 2,614 80 64 2,168 2,550 178 181 1,989 2,369
Mental Health Treatment Center1 2,688 2,872 202 234 2,486 2,638 343 324 2,143 2,314
Office of a Therapist, Psychologist, Psychiatrist, or Substance Use Treatment Professional1 5,483 5,482 406 382 5,077 5,099 684 704 4,393 4,396
General Medical Clinic or Doctor’s Office1 5,313 5,199 456 389 4,857 4,810 504 582 4,353 4,228
Hospital1 2,086 1,836 170 158 1,916 1,678 194 194 1,722 1,483
School’s Health or Counseling Center1 1,090 1,185 513 455 577 730 245 233 332 497
Some Other Place as an Outpatient1 844 812 92 66 752 747 82 104 670 643
Outpatient, Other Than General Medical Clinic or Doctor’s Office1 8,267 8,107 792 729 7,476 7,378 1,038 1,022 6,438 6,356
Medication-Assisted Treatment (MAT)                    
MAT for Alcohol Use 1,243 1,146 44a 13 1,199 1,133 95 88 1,104 1,044
MAT for Opioid Use 2,392 2,296 40 37 2,353 2,258 90 99 2,262 2,159
Telehealth Treatment3 3,575 3,979 230a 158 3,345 3,820 413 469 2,932 3,352
Prison, Jail, or Juvenile Detention Center 721 797 32 42 689 755 78 73 611 682
OTHER SERVICES                    
Support Services                    
Support Group 5,770 5,848 151 185 5,619 5,663 444 390 5,175 5,272
Peer Support Specialist or Recovery Coach 2,003 2,254 85 82 1,918 2,172 158 173 1,760 1,999
Emergency Room/Department or Detoxification                    
Emergency Room/Department 1,996 1,854 137 120 1,859 1,734 304 318 1,555 1,416
Detoxification/Withdrawal Support Services 1,178 1,169 44 48 1,133 1,121 91 127 1,043 994
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Respondents could indicate multiple types/locations for receiving substance use treatment or other services; thus, these response categories are not mutually exclusive.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
2 Other services includes treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; or detoxification/withdrawal support services. Other services questions are asked of respondents who used alcohol or drugs in their lifetime.
3 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.27B – Types and Locations of Substance Use Treatment and Other Services in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2022 and 2023
Type/Location of Treatment or Other Services Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE TREATMENT OR OTHER SERVICES1,2 5.7 5.6 5.0 4.8 5.8 5.6 5.6 5.5 5.8 5.7
SUBSTANCE USE TREATMENT1 4.6 4.5 4.6 4.4 4.7 4.5 4.8 4.7 4.6 4.5
Inpatient1 1.2 1.2 1.3 1.4 1.2 1.2 1.4 1.5 1.2 1.2
Hospital1 0.8 0.7 0.7 0.7 0.8 0.8 1.0 0.9 0.8 0.7
Residential Drug or Alcohol Rehab or Treatment Center1 0.6 0.6 0.3 0.2 0.6 0.7 0.4 0.5 0.6 0.7
Residential Mental Health Treatment Center1 0.5 0.5 0.7 0.8 0.5 0.5 0.7 0.7 0.4 0.4
Some Other Place as an Inpatient1 0.3 0.3 0.4 0.5 0.3 0.3 0.4 0.4 0.3 0.3
Outpatient1 3.5 3.5 3.7 3.3 3.5 3.5 3.5 3.5 3.5 3.5
Drug or Alcohol Rehab or Treatment Center1 0.8 0.9 0.3 0.2 0.8 1.0 0.5 0.5 0.9 1.1
Mental Health Treatment Center1 1.0 1.0 0.8 0.9 1.0 1.0 1.0 1.0 1.0 1.0
Office of a Therapist, Psychologist, Psychiatrist, or Substance Use Treatment Professional1 1.9 1.9 1.6 1.5 2.0 2.0 2.0 2.1 2.0 2.0
General Medical Clinic or Doctor’s Office1 1.9 1.8 1.8 1.5 1.9 1.9 1.4 1.7 2.0 1.9
Hospital1 0.7 0.6 0.7 0.6 0.7 0.7 0.6 0.6 0.8 0.7
School’s Health or Counseling Center1 0.4 0.4 2.0 1.8 0.2 0.3 0.7 0.7 0.1 0.2
Some Other Place as an Outpatient1 0.3 0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.3
Outpatient, Other Than General Medical Clinic or Doctor’s Office1 2.9 2.9 3.1 2.8 2.9 2.9 3.0 3.0 2.9 2.8
Medication-Assisted Treatment (MAT)                    
MAT for Alcohol Use 0.4 0.4 0.2a 0.1 0.5 0.4 0.3 0.3 0.5 0.5
MAT for Opioid Use 0.8 0.8 0.2 0.1 0.9 0.9 0.3 0.3 1.0 1.0
Telehealth Treatment3 1.3 1.4 0.9a 0.6 1.3 1.5 1.2 1.4 1.3 1.5
Prison, Jail, or Juvenile Detention Center 0.3 0.3 0.1 0.2 0.3 0.3 0.2 0.2 0.3 0.3
OTHER SERVICES                    
Support Services                    
Support Group 2.0 2.1 0.6 0.7 2.2 2.2 1.3 1.1 2.3 2.4
Peer Support Specialist or Recovery Coach 0.7 0.8 0.3 0.3 0.7 0.8 0.5 0.5 0.8 0.9
Emergency Room/Department or Detoxification                    
Emergency Room/Department 0.7 0.7 0.5 0.5 0.7 0.7 0.9 0.9 0.7 0.6
Detoxification/Withdrawal Support Services 0.4 0.4 0.2 0.2 0.4 0.4 0.3 0.4 0.5 0.4
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Respondents could indicate multiple types/locations for receiving substance use treatment or other services; thus, these response categories are not mutually exclusive.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
2 Other services includes treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; or detoxification/withdrawal support services. Other services questions are asked of respondents who used alcohol or drugs in their lifetime.
3 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.28A – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Numbers in Thousands, 2022 and 2023
Substance for Which Treatment Was Received and
Use Disorder for Specific Substance		 Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE DISORDER1 2,245 2,538 163 169 2,083 2,370 358 331 1,725 2,039
DRUGS 965 1,084 94 83 871 1,001 160 161 711 839
Marijuana 202 316 55 43 148 273 59 74 88 200
Cocaine 151 138 * * 150 128 10 * * 114
Heroin * * * * * * * * * *
Hallucinogens 20 16 * * 10 10 8 * * *
Inhalants * * * * * * * * * *
Methamphetamine 161 265 * * 159 265 * * 141 239
Prescription Psychotherapeutics 339 326 44 26 296 300 46 59 250 242
Pain Relievers 228 189 13 7 215 181 32 43 183 138
Stimulants 52 35 * 9 36 26 7 * * 21
Tranquilizers or Sedatives 63 114 * * 49 103 7 * 42 86
Tranquilizers 36 89 * * 35 83 6 * 29 67
Sedatives 29 34 * * * 26 * * * 24
Opioids 489 421 13 7 475 413 41 47 435 366
Central Nervous System Stimulants 319 434 18 * 301 416 35 40 266 376
ALCOHOL 744 915 20 30 724 885 110 107 614 778
BOTH DRUGS AND ALCOHOL 168 240 6 11 162 229 47 43 114 186
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.28B – Substances for Which Treatment Was Received as an Inpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Percentages, 2022 and 2023
Substance for Which Treatment Was Received and
Use Disorder for Specific Substance		 Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE DISORDER1 4.6 5.2 7.3 7.7 4.5 5.1 3.7 3.6 4.7 5.5
DRUGS 3.5 4.0 5.2 4.7 3.4 3.9 2.5 2.6 3.8 4.4
Marijuana 1.1 1.6 4.2 3.5 0.8 1.5 1.0 1.3 0.7 1.6
Cocaine 10.5 11.0 * * 10.5 10.6 3.9 * * 11.1
Heroin * * * * * * * * * *
Hallucinogens 3.4 3.8 * * 2.0 2.8 3.6 * * *
Inhalants * * * * * * * * * *
Methamphetamine 8.8 14.9 * * 8.8 15.1 * * 8.1 14.2
Prescription Psychotherapeutics 4.1 4.1 8.1 4.4 3.8 4.1 4.9 7.6 3.7 3.7
Pain Relievers 4.1 3.5 5.0 2.3 4.0 3.6 7.7 11.1 3.7 3.0
Stimulants 2.9 2.0 * 3.9 2.3 1.7 1.4 * * 1.8
Tranquilizers or Sedatives 2.7 5.0 * * 2.2 4.9 2.4 * 2.2 4.6
Tranquilizers 2.0 5.1 * * 2.0 5.0 2.4 * 1.9 4.5
Sedatives 3.4 3.9 * * * 3.2 * * * 3.3
Opioids 8.0 7.4 5.0 2.3 8.1 7.7 9.6 11.9 8.0 7.4
Central Nervous System Stimulants 7.1 10.0 6.8 * 7.1 10.3 4.6 7.5 7.6 10.7
ALCOHOL 2.5 3.2 2.7 4.0 2.5 3.1 1.9 2.1 2.7 3.4
BOTH DRUGS AND ALCOHOL 2.1 3.2 1.9 3.1 2.1 3.2 1.9 2.1 2.2 3.6
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Includes data from respondents who reported that they received inpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.29A – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Numbers in Thousands, 2022 and 2023
Substance for Which Treatment Was Received and
Use Disorder for Specific Substance		 Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE DISORDER1 5,406 5,379 365 325 5,041 5,054 818 789 4,223 4,265
DRUGS 2,227 2,388 199 179 2,027 2,209 298 347 1,730 1,862
Marijuana 530 714 134 104 396 610 147 228 248 382
Cocaine 217 265 * * 216 247 21 * 194 *
Heroin 340 * * * 340 * * * * *
Hallucinogens 35 * * * 15 * * * * *
Inhalants * * * * * * * * * *
Methamphetamine 282 399 * * 278 389 * * 261 364
Prescription Psychotherapeutics 780 879 66 50 714 829 86 103 629 726
Pain Relievers 505 595 36 28 469 567 46 49 423 518
Stimulants 119 120 28 17 91 103 23 * 68 63
Tranquilizers or Sedatives 166 180 * * 153 171 19 * 134 147
Tranquilizers 133 148 * * 127 142 * * 110 121
Sedatives 41 54 * * 38 47 * * * 45
Opioids 884 903 36 28 848 875 55 53 793 822
Central Nervous System Stimulants 569 734 34 * 535 695 58 80 477 615
ALCOHOL 1,445 1,427 30 45 1,416 1,382 198 208 1,218 1,174
BOTH DRUGS AND ALCOHOL 337 322 19 24 318 298 51 80 267 218
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.29B – Substances for Which Treatment Was Received as an Outpatient in Past Year: Among People Aged 12 or Older; by Past Year Use Disorder for Specific Substances and Age Group, Percentages, 2022 and 2023
Substance for Which Treatment Was Received and
Use Disorder for Specific Substance		 Aged 12+
(2022)		 Aged 12+
(2023)		 Aged 12-17
(2022)		 Aged 12-17
(2023)		 Aged 18+
(2022)		 Aged 18+
(2023)		 Aged 18-25
(2022)		 Aged 18-25
(2023)		 Aged 26+
(2022)		 Aged 26+
(2023)
SUBSTANCE USE DISORDER1 11.1 11.1 16.4 14.8 10.8 10.9 8.5 8.5 11.5 11.5
DRUGS 8.2 8.8 11.0 10.1 8.0 8.7 4.6 5.7 9.1 9.7
Marijuana 2.8 3.7 10.3 8.5 2.2 3.4 2.6 4.0 2.1 3.1
Cocaine 15.1 21.1 * * 15.1 20.4 8.0 * 16.7 *
Heroin 37.8 * * * 37.9 * * * * *
Hallucinogens 5.8 * * * 2.9 * * * * *
Inhalants * * * * * * * * * *
Methamphetamine 15.4 22.4 * * 15.3 22.1 * * 15.0 21.5
Prescription Psychotherapeutics 9.5 11.1 12.2 8.4 9.3 11.4 9.1 13.4 9.3 11.1
Pain Relievers 9.0 11.1 13.5 8.8 8.8 11.3 11.1 12.6 8.6 11.2
Stimulants 6.5 7.0 10.7 7.0 5.8 7.0 4.9 * 6.2 5.5
Tranquilizers or Sedatives 7.0 8.0 * * 6.9 8.1 6.4 * 7.0 7.8
Tranquilizers 7.4 8.5 * * 7.3 8.6 * * 7.3 8.1
Sedatives 4.9 6.2 * * 4.9 5.9 * * * 6.2
Opioids 14.4 15.9 13.5 8.8 14.5 16.3 13.0 13.4 14.6 16.6
Central Nervous System Stimulants 12.6 17.0 12.8 * 12.6 17.1 7.7 15.2 13.7 17.4
ALCOHOL 4.9 4.9 3.9 6.0 4.9 4.9 3.5 4.1 5.3 5.1
BOTH DRUGS AND ALCOHOL 4.2 4.3 5.7 7.0 4.1 4.1 2.0 4.0 5.1 4.2
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Includes data from respondents who reported that they received outpatient substance use treatment but did not report the substance for which they received treatment.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.30A – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Past Year Drug Use Disorder, Past Year Alcohol Use Disorder, Past Year Drug and Alcohol Use Disorder, and Past Year Substance Use Disorder, Numbers in Thousands, 2022 and 2023
Substance/Age Group Treatment for
Drugs
(2022)		 Treatment for
Drugs
(2023)		 Treatment for
Alcohol
(2022)		 Treatment for
Alcohol
(2023)		 Treatment for
Both Drugs
and Alcohol
(2022)		 Treatment for
Both Drugs
and Alcohol
(2023)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment for
Substance
Unspecified1
(2023)		 Treatment for
Substance
Use1
(2022)		 Treatment for
Substance
Use1
(2023)
DRUGS 3,569 3,467 1,581 1,628 1,084 1,058 1,324 1,106 5,390 5,144
12-17 292 239 73 85 59 58 115 107 420 373
18 or Older 3,277 3,229 1,509 1,543 1,025 1,000 1,209 999 4,970 4,771
18-25 515 525 273 284 163 193 312 239 937 855
26 or Older 2,763 2,704 1,236 1,259 862 807 896 760 4,033 3,916
ALCOHOL 1,407 1,442 2,247 2,267 795 880 792 853 3,651 3,682
12-17 86 80 54 73 39 43 46 48 148 159
18 or Older 1,321 1,362 2,193 2,194 756 837 746 805 3,504 3,524
18-25 294 321 306 356 145 193 161 191 617 675
26 or Older 1,027 1,041 1,887 1,838 612 644 584 614 2,886 2,848
BOTH DRUGS AND ALCOHOL 1,037 1,014 884 1,041 560 645 428 352 1,789 1,762
12-17 78 62 41 60 34 38 * 24 115 109
18 or Older 959 952 843 981 526 607 398 328 1,674 1,653
18-25 230 263 168 241 107 173 100 113 390 443
26 or Older 729 689 675 740 419 434 298 215 1,283 1,210
SUBSTANCE USE DISORDER 3,940 3,895 2,944 2,854 1,319 1,293 1,688 1,607 7,253 7,064
12-17 300 257 85 98 64 63 132 131 453 423
18 or Older 3,640 3,639 2,859 2,756 1,255 1,230 1,556 1,476 6,800 6,641
18-25 580 584 411 399 201 213 374 317 1,164 1,087
26 or Older 3,060 3,055 2,448 2,357 1,054 1,017 1,182 1,159 5,636 5,555
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.30B – Received Substance Use Treatment in Past Year: Among People Aged 12 or Older; by Age Group and Past Year Drug Use Disorder, Past Year Alcohol Use Disorder, Past Year Drug and Alcohol Use Disorder, and Past Year Substance Use Disorder, Percentages, 2022 and 2023
Substance/Age Group Treatment for
Drugs
(2022)		 Treatment for
Drugs
(2023)		 Treatment for
Alcohol
(2022)		 Treatment for
Alcohol
(2023)		 Treatment for
Both Drugs
and Alcohol
(2022)		 Treatment for
Both Drugs
and Alcohol
(2023)		 Treatment for
Substance
Unspecified1
(2022)		 Treatment for
Substance
Unspecified1
(2023)		 Treatment for
Substance
Use1
(2022)		 Treatment for
Substance
Use1
(2023)
DRUGS 13.1 12.8 5.8 6.0 4.0 3.9 4.9 4.1 19.8 18.9
12-17 16.1 13.4 4.0 4.8 3.3 3.2 6.3 6.0 23.2 21.0
18 or Older 12.9 12.7 5.9 6.1 4.0 3.9 4.8 3.9 19.6 18.8
18-25 7.9 8.6 4.2 4.6 2.5 3.2 4.8 3.9 14.5 14.0
26 or Older 14.6 14.0 6.5 6.5 4.6 4.2 4.7 3.9 21.3 20.3
ALCOHOL 4.8 5.0 7.6 7.9 2.7 3.0 2.7 3.0 12.4 12.8
12-17 11.4 10.6 7.2 9.7 5.2 5.7 6.1 6.4 19.6 21.0
18 or Older 4.6 4.8 7.6 7.8 2.6 3.0 2.6 2.9 12.2 12.5
18-25 5.2 6.3 5.4 6.9 2.5 3.8 2.8 3.7 10.9 13.2
26 or Older 4.4 4.5 8.2 8.0 2.6 2.8 2.5 2.7 12.5 12.4
BOTH DRUGS AND ALCOHOL 12.9 13.4 11.0 13.8 7.0 8.5 5.3 4.7 22.2 23.3
12-17 23.0 18.1 12.2 17.5 10.0 10.9 * 7.0 34.0 31.6
18 or Older 12.4 13.2 10.9 13.6 6.8 8.4 5.2 4.6 21.7 22.9
18-25 9.2 13.1 6.7a 12.0 4.3a 8.6 4.0 5.6 15.6a 22.1
26 or Older 14.0 13.3 13.0 14.2 8.0 8.4 5.7 4.1 24.6 23.3
SUBSTANCE USE DISORDER 8.1 8.0 6.0 5.9 2.7 2.7 3.5 3.3 14.9 14.6
12-17 13.5 11.7 3.8 4.5 2.9 2.9 5.9 6.0 20.3 19.3
18 or Older 7.8 7.9 6.1 6.0 2.7 2.7 3.3 3.2 14.6 14.4
18-25 6.0 6.3 4.3 4.3 2.1 2.3 3.9 3.4 12.0 11.8
26 or Older 8.3 8.2 6.6 6.4 2.9 2.7 3.2 3.1 15.3 15.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Substance use treatment measures include data from respondents who indicated that they received treatment but did not specify the substance(s) for which it was received.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.31A – Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older with Substance Use Disorder in Past Year; by Substance Use Disorder Severity Level and Age Group, Numbers in Thousands, 2022 and 2023
Substance Use Disorder Severity Level/Age Group Among People Aged 12 or Older with Substance Use Disorder in Past Year
Received
Substance Use
Treatment
(SU Tx)
(2022)		 Received
Substance Use
Treatment
(SU Tx)
(2023)		 Did Not Receive
SU Tx
(2022)		 Did Not Receive
SU Tx
(2023)		 Received SU Tx
or Other
Services1
(2022)		 Received SU Tx
or Other
Services1
(2023)		 Did Not Receive
SU Tx or Other
Services1
(2022)		 Did Not Receive
SU Tx or Other
Services1
(2023)
Any SUD 7,253 7,064 41,469 41,400 8,351 8,148 40,371 40,316
12-17 453 423 1,775 1,769 488 466 1,740 1,725
18 or Older 6,800 6,641 39,694 39,631 7,863 7,681 38,631 38,591
18-25 1,164 1,087 8,505 8,141 1,361 1,280 8,307 7,949
26 or Older 5,636 5,555 31,190 31,489 6,502 6,402 30,323 30,642
Mild SUD 2,218 2,113 24,594 24,961 2,607 2,440 24,205 24,635
12-17 157 145 1,038 1,078 167 169 1,028 1,055
18 or Older 2,061 1,968 23,555 23,883 2,440 2,271 23,177 23,580
18-25 328 274 4,224 4,098 375 311 4,178 4,061
26 or Older 1,733 1,694 19,331 19,785 2,065 1,960 18,999 19,519
Moderate SUD 1,524 1,492 9,501 9,488 1,725 1,758 9,300 9,222
12-17 112 111 435 335 119 116 427 330
18 or Older 1,412 1,381 9,066 9,152 1,605 1,641 8,873 8,892
18-25 229 240 2,357 2,167 289 289 2,298 2,118
26 or Older 1,183 1,142 6,708 6,985 1,316 1,352 6,575 6,775
Severe SUD 3,511 3,459 7,375 6,951 4,020 3,950 6,866 6,459
12-17 185 167 302 355 201 182 285 340
18 or Older 3,326 3,292 7,073 6,596 3,818 3,769 6,581 6,119
18-25 606 573 1,923 1,876 697 680 1,832 1,770
26 or Older 2,720 2,719 5,150 4,719 3,121 3,089 4,749 4,349
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other services includes treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; or detoxification/withdrawal support services. Other services questions are asked of respondents who used alcohol or drugs in their lifetime.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.31B – Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older with Substance Use Disorder in Past Year; by Substance Use Disorder Severity Level and Age Group, Percentages, 2022 and 2023
Substance Use Disorder Severity Level/Age Group Among People Aged 12 or Older with Substance Use Disorder in Past Year
Received
Substance Use
Treatment
(SU Tx)
(2022)		 Received
Substance Use
Treatment
(SU Tx)
(2023)		 Did Not Receive
SU Tx
(2022)		 Did Not Receive
SU Tx
(2023)		 Received SU Tx
or Other
Services1
(2022)		 Received SU Tx
or Other
Services1
(2023)		 Did Not Receive
SU Tx or Other
Services1
(2022)		 Did Not Receive
SU Tx or Other
Services1
(2023)
Any SUD 14.9 14.6 85.1 85.4 17.1 16.8 82.9 83.2
12-17 20.3 19.3 79.7 80.7 21.9 21.3 78.1 78.7
18 or Older 14.6 14.4 85.4 85.6 16.9 16.6 83.1 83.4
18-25 12.0 11.8 88.0 88.2 14.1 13.9 85.9 86.1
26 or Older 15.3 15.0 84.7 85.0 17.7 17.3 82.3 82.7
Mild SUD 8.3 7.8 91.7 92.2 9.7 9.0 90.3 91.0
12-17 13.1 11.9 86.9 88.1 14.0 13.8 86.0 86.2
18 or Older 8.0 7.6 92.0 92.4 9.5 8.8 90.5 91.2
18-25 7.2 6.3 92.8 93.7 8.2 7.1 91.8 92.9
26 or Older 8.2 7.9 91.8 92.1 9.8 9.1 90.2 90.9
Moderate SUD 13.8 13.6 86.2 86.4 15.6 16.0 84.4 84.0
12-17 20.4 24.8 79.6 75.2 21.8 26.0 78.2 74.0
18 or Older 13.5 13.1 86.5 86.9 15.3 15.6 84.7 84.4
18-25 8.9 10.0 91.1 90.0 11.2 12.0 88.8 88.0
26 or Older 15.0 14.0 85.0 86.0 16.7 16.6 83.3 83.4
Severe SUD 32.3 33.2 67.7 66.8 36.9 38.0 63.1 62.0
12-17 38.0 31.9 62.0 68.1 41.4 34.8 58.6 65.2
18 or Older 32.0 33.3 68.0 66.7 36.7 38.1 63.3 61.9
18-25 24.0 23.4 76.0 76.6 27.6 27.7 72.4 72.3
26 or Older 34.6 36.6 65.4 63.4 39.7 41.5 60.3 58.5
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other services includes treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; or detoxification/withdrawal support services. Other services questions are asked of respondents who used alcohol or drugs in their lifetime.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.32A – Classified as Needing Substance Use Treatment: Among People Aged 12 or Older; Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older Classified as Needing Substance Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands and Percentages, 2022 and 2023
Demographic Characteristic Among the Total Population Among People Classified as Needing Substance Use Treatment (SU Tx)
Classified as
Needing SU Tx
(2022)		 Classified as
Needing SU Tx
(2023)		 % Who Received
SU Tx
(2022)		 % Who Received
SU Tx
(2023)		 % Who Did Not
Receive SU Tx
(2022)		 % Who Did Not
Receive SU Tx
(2023)		 % Who Received
SU Tx or Other
Services1
(2022)		 % Who Received
SU Tx or Other
Services1
(2023)		 % Who Did Not
Receive SU Tx or
Other Services1
(2022)		 % Who Did Not
Receive SU Tx or
Other Services1
(2023)
TOTAL 54,575 54,186 24.0 23.6 76.0 76.4 26.0 25.6 74.0 74.4
AGE GROUP                    
12-17 2,960 2,897 40.0 38.9 60.0 61.1 41.2 40.4 58.8 59.6
18 or Older 51,616 51,290 23.1 22.7 76.9 77.3 25.2 24.8 74.8 75.2
18-25 10,178 9,756 16.4 16.6 83.6 83.4 18.4 18.5 81.6 81.5
26 or Older 41,438 41,534 24.7 24.2 75.3 75.8 26.8 26.2 73.2 73.8
SEX                    
Male 30,873 30,340 23.5 21.0 76.5 79.0 25.6 23.1 74.4 76.9
Female 23,702 23,846 24.7 26.9 75.3 73.1 26.6 28.7 73.4 71.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 44,688 45,055 24.6 23.3 75.4 76.7 26.6 25.1 73.4 74.9
AIAN 410 409 * * * * * * * *
Asian 1,705 1,840 * 20.8 * 79.2 * 21.7 * 78.3
Black or African American 7,023 6,847 22.5 18.9 77.5 81.1 24.7 21.1 75.3 78.9
NHOPI * * * * * * * * * *
White 33,798 33,965 24.9 24.2 75.1 75.8 26.9 26.1 73.1 73.9
Two or More Races 1,415 1,624 24.6 21.5 75.4 78.5 28.1 23.2 71.9 76.8
Hispanic or Latino 9,887 9,131 21.4 25.3 78.6 74.7 23.5 28.0 76.5 72.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents were classified as needing substance use treatment if they met DSM-5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other services includes treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; or detoxification/withdrawal support services. Other services questions are asked of respondents who used alcohol or drugs in their lifetime.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.32B – Classified as Needing Substance Use Treatment: Among People Aged 12 or Older; Receipt of Substance Use Treatment and Receipt of Substance Use Treatment or Other Services in Past Year: Among People Aged 12 or Older Classified as Needing Substance Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Among the Total Population Among People Classified as Needing Substance Use Treatment (SU Tx)
Classified as
Needing SU Tx
(2022)		 Classified as
Needing SU Tx
(2023)		 % Who Received
SU Tx
(2022)		 % Who Received
SU Tx
(2023)		 % Who Did Not
Receive SU Tx
(2022)		 % Who Did Not
Receive SU Tx
(2023)		 % Who Received
SU Tx or Other
Services1
(2022)		 % Who Received
SU Tx or Other
Services1
(2023)		 % Who Did Not
Receive SU Tx or
Other Services1
(2022)		 % Who Did Not
Receive SU Tx or
Other Services1
(2023)
TOTAL 19.4 19.1 24.0 23.6 76.0 76.4 26.0 25.6 74.0 74.4
AGE GROUP                    
12-17 11.5 11.2 40.0 38.9 60.0 61.1 41.2 40.4 58.8 59.6
18 or Older 20.1 19.9 23.1 22.7 76.9 77.3 25.2 24.8 74.8 75.2
18-25 29.3 28.7 16.4 16.6 83.6 83.4 18.4 18.5 81.6 81.5
26 or Older 18.7 18.6 24.7 24.2 75.3 75.8 26.8 26.2 73.2 73.8
SEX                    
Male 22.3 21.9 23.5 21.0 76.5 79.0 25.6 23.1 74.4 76.9
Female 16.5 16.5 24.7 26.9 75.3 73.1 26.6 28.7 73.4 71.3
HISPANIC ORIGIN AND RACE                    
Not Hispanic or Latino 19.3 19.5 24.6 23.3 75.4 76.7 26.6 25.1 73.4 74.9
AIAN 28.0 30.6 * * * * * * * *
Asian 10.0 10.5 * 20.8 * 79.2 * 21.7 * 78.3
Black or African American 20.4 19.7 22.5 18.9 77.5 81.1 24.7 21.1 75.3 78.9
NHOPI * * * * * * * * * *
White 19.8 19.9 24.9 24.2 75.1 75.8 26.9 26.1 73.1 73.9
Two or More Races 24.1 26.2 24.6 21.5 75.4 78.5 28.1 23.2 71.9 76.8
Hispanic or Latino 19.4a 17.5 21.4 25.3 78.6 74.7 23.5 28.0 76.5 72.0
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Respondents were classified as needing substance use treatment if they met DSM-5 criteria for a drug or alcohol use disorder or received treatment for drug or alcohol use.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: The substance use treatment measures have added uncertainty because of the high proportion of respondents in the “substance unspecified” category for substance use treatment. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
1 Other services includes treatment for drug or alcohol use through support group services; peer support specialist or recovery coach services; treatment received in an emergency room/department; or detoxification/withdrawal support services. Other services questions are asked of respondents who used alcohol or drugs in their lifetime.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.33A – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Any Perceived
Unmet Need
(2022)		 Any Perceived
Unmet Need
(2023)		 Sought
Treatment
(2022)		 Sought
Treatment
(2023)		 Did Not Seek
Treatment but
Thought Should
Get Treatment
(2022)		 Did Not Seek
Treatment but
Thought Should
Get Treatment
(2023)		 Did Not
Perceive Need
for Substance
Use Treatment
(2022)		 Did Not
Perceive Need
for Substance
Use Treatment
(2023)
TOTAL 42 58 8 9 34 49 1,665 1,646
AGE GROUP                
12-13 * * * * * * * *
14-15 17 19 * * 17 11 540 575
16-17 18 35 3 1 15 34 921 935
SEX                
Male 10 19 8 * 1a 19 766 662
Female 32 39 <1 * 32 30 899 984
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 35 42 8 * 27 42 1,147 1,121
AIAN * * * * * * * *
Asian * * * * * * * *
Black or African American * * * * * * * *
NHOPI * * * * * * * *
White 25 31 3 * 22 31 794 791
Two or More Races * * * * * * * *
Hispanic or Latino 7 16 * * 7 7 518 525
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Some 2022 estimates may differ from previously published estimates due to updates.
NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.33B – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Among People Aged 12 to 17 with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Any Perceived
Unmet Need
(2022)		 Any Perceived
Unmet Need
(2023)		 Sought
Treatment
(2022)		 Sought
Treatment
(2023)		 Did Not Seek
Treatment but
Thought Should
Get Treatment
(2022)		 Did Not Seek
Treatment but
Thought Should
Get Treatment
(2023)		 Did Not
Perceive Need
for Substance
Use Treatment
(2022)		 Did Not
Perceive Need
for Substance
Use Treatment
(2023)
TOTAL 2.5 3.4 0.5 0.5 2.0 2.8 97.5 96.6
AGE GROUP                
12-13 * * * * * * * *
14-15 3.0 3.1 * * 3.0 1.8 97.0 96.9
16-17 1.9 3.6 0.3 0.1 1.6 3.4 98.1 96.4
SEX                
Male 1.2 2.8 1.0 * 0.2a 2.7 98.8 97.2
Female 3.5 3.8 <0.1 * 3.5 2.9 96.5 96.2
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 3.0 3.6 0.7 * 2.3 3.5 97.0 96.4
AIAN * * * * * * * *
Asian * * * * * * * *
Black or African American * * * * * * * *
NHOPI * * * * * * * *
White 3.0 3.7 0.4 * 2.7 3.7 97.0 96.3
Two or More Races * * * * * * * *
Hispanic or Latino 1.2 2.9 * * 1.2 1.3 98.8 97.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Some 2022 estimates may differ from previously published estimates due to updates.
NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.34A – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Numbers in Thousands, 2022 and 2023
Demographic Characteristic Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Any Perceived
Unmet Need
(2022)		 Any Perceived
Unmet Need
(2023)		 Sought
Treatment
(2022)		 Sought
Treatment
(2023)		 Did Not Seek
Treatment but
Thought Should
Get Treatment
(2022)		 Did Not Seek
Treatment but
Thought Should
Get Treatment
(2023)		 Did Not
Perceive Need
for Substance
Use Treatment
(2022)		 Did Not
Perceive Need
for Substance
Use Treatment
(2023)
TOTAL 2,079 2,048 313 189 1,765 1,858 36,805 36,659
AGE GROUP                
18-25 410 337 32 28 377 308 7,958 7,710
26 or Older 1,669 1,711 280 161 1,387 1,550 28,847 28,949
26-49 1,286 1,087 257 98 1,028 989 18,005 18,032
50 or Older 383 624 23 63 360 561 10,842 10,918
SEX                
Male 1,053 1,105 134 112 918 993 21,255 21,647
Female 1,025 942 179 77 847 866 15,550 15,013
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 1,582 1,874 170 171 1,410 1,703 30,202 30,777
AIAN * 19 * 1 * 19 * 248
Asian 39 * * * 26 * 1,186 *
Black or African American 246 187 5 20 241 168 4,824 5,024
NHOPI * * * * * * * *
White 1,205 1,446 136 129 1,068 1,316 22,845 22,912
Two or More Races 70 99 * 12 61 86 911 1,078
Hispanic or Latino 497b 174 142 18 354a 156 6,604 5,883
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Some 2022 estimates may differ from previously published estimates due to updates.
NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.34B – Perceived Unmet Need for Substance Use Treatment in Past Year: Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year; by Demographic Characteristics, Percentages, 2022 and 2023
Demographic Characteristic Among People Aged 18 or Older with a Past Year Substance Use Disorder Who Did Not Receive Substance Use Treatment in Past Year
Any Perceived
Unmet Need
(2022)		 Any Perceived
Unmet Need
(2023)		 Sought
Treatment
(2022)		 Sought
Treatment
(2023)		 Did Not Seek
Treatment but
Thought Should
Get Treatment
(2022)		 Did Not Seek
Treatment but
Thought Should
Get Treatment
(2023)		 Did Not
Perceive Need
for Substance
Use Treatment
(2022)		 Did Not
Perceive Need
for Substance
Use Treatment
(2023)
TOTAL 5.3 5.3 0.8 0.5 4.5 4.8 94.7 94.7
AGE GROUP                
18-25 4.9 4.2 0.4 0.4 4.5 3.8 95.1 95.8
26 or Older 5.5 5.6 0.9 0.5 4.5 5.1 94.5 94.4
26-49 6.7 5.7 1.3 0.5 5.3 5.2 93.3 94.3
50 or Older 3.4 5.4 0.2 0.5 3.2 4.9 96.6 94.6
SEX                
Male 4.7 4.9 0.6 0.5 4.1 4.4 95.3 95.1
Female 6.2 5.9 1.1 0.5 5.1 5.4 93.8 94.1
HISPANIC ORIGIN AND RACE                
Not Hispanic or Latino 5.0 5.7 0.5 0.5 4.4 5.2 95.0 94.3
AIAN * 7.2 * 0.2 * 7.0 * 92.8
Asian 3.2 * * * 2.1 * 96.8 *
Black or African American 4.9 3.6 0.1 0.4 4.8 3.2 95.1 96.4
NHOPI * * * * * * * *
White 5.0 5.9 0.6 0.5 4.4 5.4 95.0 94.1
Two or More Races 7.1 8.4 * 1.1 6.3 7.3 92.9 91.6
Hispanic or Latino 7.0a 2.9 2.0 0.3 5.0a 2.6 93.0a 97.1
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Some 2022 estimates may differ from previously published estimates due to updates.
NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Substance use disorder is based on DSM-5 criteria. See the 2023 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on who was eligible to receive questions on substance use disorder.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.35A – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 18 or Older Who Did Not Receive Substance Use Treatment and Had a Perceived Unmet Need for Substance Use Treatment in Past Year; Numbers in Thousands, 2022 and 2023
Reason for Not Receiving Substance Use Treatment Total
(2022)		 Total
(2023)
Thought It Would Cost Too Much 1,027 896
Did Not Have Health Insurance Coverage for Alcohol or Drug Use Treatment 891 629
Health Insurance Would Not Pay Enough of Costs for Treatment 724 644
Did Not Know How or Where to Get Treatment 1,114 839
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to 783 595
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to 257 289
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times that Worked for Them 501 489
Did Not Have Enough Time for Treatment 886 861
Worried That Information Would Not Be Kept Private 772 720
Worried about What People Would Think or Say if They Got Treatment 978 936
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children 792 686
Not Ready to Start Treatment 1,400 1,366
Not Ready to Stop or Cut Back Using Alcohol or Drugs 1,176 1,230
Thought They Should Have Been Able to Handle Their Alcohol or Drug Use on Their Own 1,688 1,581
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment 356 369
Thought They Would Be Forced to Stay in Rehab or Treatment against Their Will 511 508
Did Not Think Treatment Would Help Them 578 531
Thought No One Would Care if They Got Better 399 373
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving substance use treatment data were excluded.
NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.
240520
Table 5.35B – Detailed Reasons for Not Receiving Substance Use Treatment in Past Year: Among People Aged 18 or Older Who Did Not Receive Substance Use Treatment and Had a Perceived Unmet Need for Substance Use Treatment in Past Year; Percentages, 2022 and 2023
Reason for Not Receiving Substance Use Treatment Total
(2022)		 Total
(2023)
Thought It Would Cost Too Much 45.6 40.1
Did Not Have Health Insurance Coverage for Alcohol or Drug Use Treatment 40.1a 28.6
Health Insurance Would Not Pay Enough of Costs for Treatment 34.0 30.7
Did Not Know How or Where to Get Treatment 48.9a 37.1
Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to 35.2 27.4
No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to 11.7 13.4
Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times that Worked for Them 22.2 21.9
Did Not Have Enough Time for Treatment 39.4 39.0
Worried That Information Would Not Be Kept Private 34.4 32.4
Worried about What People Would Think or Say if They Got Treatment 42.9 41.5
Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children 34.9 30.9
Not Ready to Start Treatment 61.7 62.3
Not Ready to Stop or Cut Back Using Alcohol or Drugs 52.4 55.9
Thought They Should Have Been Able to Handle Their Alcohol or Drug Use on Their Own 75.6 70.7
Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment 15.8 16.7
Thought They Would Be Forced to Stay in Rehab or Treatment against Their Will 23.0 22.9
Did Not Think Treatment Would Help Them 26.1 24.4
Thought No One Would Care if They Got Better 17.7 16.8
* = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues.
NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime.
NOTE: Respondents could indicate multiple reasons for not receiving substance use treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving substance use treatment data were excluded.
NOTE: Respondents were classified as having a perceived unmet need for substance use treatment (SU Tx) if they did not receive SU Tx in the past year and sought or thought they should get treatment. Respondents with unknown information for perceptions of need for SU Tx were excluded.
a,b The difference between this estimate and the 2023 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2022 and 2023.

Go to Top of PageGo to the Table of Contents